https://pharmadispatch.com/news/looking-ahead-to-2016 2016-01-04T11:21:01+11:00 https://pharmadispatch.com/news/new-cabinet-documents-reveal-how-little-things-have-changed 2016-01-11T17:00:01+11:00 https://pharmadispatch.com/news/government-knew-about-higher-panadol-costs 2016-01-11T17:00:01+11:00 https://pharmadispatch.com/news/wholesalers-target-review-with-new-leadership 2016-01-11T17:00:01+11:00 https://pharmadispatch.com/news/pbac-wants-parallel-process-change 2016-01-11T17:00:01+11:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-march-pbac 2016-01-11T17:00:01+11:00 https://pharmadispatch.com/news/shire-set-to-announce-baxalta-takeover 2016-01-11T17:00:01+11:00 https://pharmadispatch.com/news/response-raises-more-questions 2016-01-12T17:00:01+11:00 https://pharmadispatch.com/news/looking-ahead-and-beyond-2016 2016-01-12T17:00:01+11:00 https://pharmadispatch.com/news/jakavi-listing-date-confirmed 2016-01-12T17:00:01+11:00 https://pharmadispatch.com/news/shire-and-baxalta-agree-merger 2016-01-12T17:00:01+11:00 https://pharmadispatch.com/news/still-no-word-on-pbac-member 2016-01-13T17:00:01+11:00 https://pharmadispatch.com/news/gilead-funds-nine-research-projects 2016-01-13T17:00:01+11:00 https://pharmadispatch.com/news/msd-acquires-uk-based-cancer-company 2016-01-13T17:00:01+11:00 https://pharmadispatch.com/news/greens-want-faster-action-on-prep 2016-01-13T17:00:01+11:00 https://pharmadispatch.com/news/savings-outstrip-cost-of-new-listings 2016-01-14T17:00:01+11:00 https://pharmadispatch.com/news/psa-leadership-program 2016-01-14T17:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-bms-immunotherapy 2016-01-14T17:00:01+11:00 https://pharmadispatch.com/news/priceline-partners-with-kyrgios 2016-01-14T17:00:01+11:00 https://pharmadispatch.com/news/patient-anger-palpable-says-guild 2016-01-14T17:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-interim-ceo 2016-01-14T20:09:01+11:00 https://pharmadispatch.com/news/gsk-new-approach-drives-organisational-change 2016-01-15T17:00:01+11:00 https://pharmadispatch.com/news/who-is-the-ma-interim-ceo 2016-01-15T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-structures-for-potential-split 2016-01-15T17:00:01+11:00 https://pharmadispatch.com/news/michael-wonder-looks-back-at-2015-tga-approvals 2016-01-18T17:00:01+11:00 https://pharmadispatch.com/news/who-is-really-misleading-consumers-on-panadol-osteo 2016-01-18T17:00:01+11:00 https://pharmadispatch.com/news/combinations-obliterated-by-price-cuts 2016-01-18T17:00:01+11:00 https://pharmadispatch.com/news/french-study-shut-down-after-serious-adverse-events 2016-01-18T17:00:01+11:00 https://pharmadispatch.com/news/questions-emerge-over-price-cuts 2016-01-18T17:00:01+11:00 https://pharmadispatch.com/news/lundbecks-di-carlo-promoted-to-us 2016-01-18T21:27:01+11:00 https://pharmadispatch.com/news/patients-want-panadol-osteo-review 2016-01-19T17:00:01+11:00 https://pharmadispatch.com/news/michael-wonder-looks-at-cancer-approvals 2016-01-19T17:00:01+11:00 https://pharmadispatch.com/news/another-biosimilar-fast-approaching 2016-01-19T17:00:01+11:00 https://pharmadispatch.com/news/generics-dominate-february-pbs-schedule-update 2016-01-19T17:00:01+11:00 https://pharmadispatch.com/news/the-smart-move-is-very-clear 2016-01-20T17:00:01+11:00 https://pharmadispatch.com/news/financial-loss-as-funding-cut-hits-consumer-body 2016-01-20T17:00:01+11:00 https://pharmadispatch.com/news/farmaforce-appoints-first-pharmacy-team 2016-01-20T17:00:01+11:00 https://pharmadispatch.com/news/michael-wonder-pbac-and-pbs-in-2015 2016-01-20T17:00:01+11:00 https://pharmadispatch.com/news/promotion-for-ex-novartis-australia-boss 2016-01-20T17:00:01+11:00 https://pharmadispatch.com/news/changes-not-limited-to-industry 2016-01-21T17:00:01+11:00 https://pharmadispatch.com/news/consumers-facing-panadol-osteo-price-rise 2016-01-21T17:00:01+11:00 https://pharmadispatch.com/news/cancer-medicines-making-headlines-again 2016-01-21T17:00:01+11:00 https://pharmadispatch.com/news/lundbeck-still-in-pursuit-of-damages 2016-01-21T17:00:01+11:00 https://pharmadispatch.com/news/one-new-medicine-for-new-zealand-patients-in-2015 2016-01-22T17:00:01+11:00 https://pharmadispatch.com/news/perception-and-reality-when-it-comes-to-vaccination 2016-01-22T17:00:01+11:00 https://pharmadispatch.com/news/ma-board-gets-underway-in-2016 2016-01-22T17:00:01+11:00 https://pharmadispatch.com/news/massive-panadol-osteo-switch-in-2016 2016-01-22T17:07:01+11:00 https://pharmadispatch.com/news/nz-could-be-a-canary-in-the-coal-mine-for-australia 2016-01-25T17:00:01+11:00 https://pharmadispatch.com/news/companies-want-action-on-antibiotics 2016-01-25T17:00:01+11:00 https://pharmadispatch.com/news/competition-driving-down-private-prices 2016-01-25T17:00:01+11:00 https://pharmadispatch.com/news/gavi-commits-to-msd-ebola-vaccine 2016-01-25T17:00:01+11:00 https://pharmadispatch.com/news/msds-fiedler-proud-of-cultural-transformation 2016-01-27T17:00:01+11:00 https://pharmadispatch.com/news/official-recognised-for-modernising-pbs 2016-01-27T17:00:01+11:00 https://pharmadispatch.com/news/fda-sets-biosimilar-review-date 2016-01-27T17:00:01+11:00 https://pharmadispatch.com/news/jj-reports-higher-profit-despite-currency-impact 2016-01-27T17:00:01+11:00 https://pharmadispatch.com/news/cpi-reports-pharmaceutical-price-drop 2016-01-28T17:00:01+11:00 https://pharmadispatch.com/news/whats-in-a-name 2016-01-28T17:00:01+11:00 https://pharmadispatch.com/news/uk-says-no-to-infliximab-substitution 2016-01-28T17:00:01+11:00 https://pharmadispatch.com/news/sigma-to-offer-hearing-checks 2016-01-28T17:00:01+11:00 https://pharmadispatch.com/news/gmwg-communiques-give-little-away 2016-01-28T17:00:01+11:00 https://pharmadispatch.com/news/currency-and-alcon-hit-to-novartis-growth 2016-01-28T17:00:01+11:00 https://pharmadispatch.com/news/department-confirms-limits-of-5-cut 2016-02-02T17:00:01+11:00 https://pharmadispatch.com/news/api-retail-grows-as-dispensary-declines 2016-01-29T17:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-confirms-diabetes-therapy-now-approved-for-weight-l 2016-01-29T17:00:01+11:00 https://pharmadispatch.com/news/msd-licenses-australian-cancer-discovery 2016-01-29T17:00:01+11:00 https://pharmadispatch.com/news/board-changes-for-asmi 2016-01-29T17:00:01+11:00 https://pharmadispatch.com/news/first-board-meeting-for-new-ceo 2016-01-29T17:00:01+11:00 https://pharmadispatch.com/news/financial-results-bms-and-biogen 2016-01-29T17:00:01+11:00 https://pharmadispatch.com/news/think-about-the-value-of-others-first 2016-02-01T17:00:01+11:00 https://pharmadispatch.com/news/treasury-secretary-joins-offset-chorus 2016-02-01T17:00:01+11:00 https://pharmadispatch.com/news/gbma-scraps-spending-reports 2016-02-01T17:00:01+11:00 https://pharmadispatch.com/news/chf-says-scrap-co-pay-hike-1 2016-02-01T17:00:01+11:00 https://pharmadispatch.com/news/some-good-news-for-ma-on-biosimilars 2016-02-01T17:00:01+11:00 https://pharmadispatch.com/news/results-amgen-and-lilly 2016-02-01T17:00:01+11:00 https://pharmadispatch.com/news/treasury-quantifies-gst-on-medicines 2016-02-02T17:00:01+11:00 https://pharmadispatch.com/news/sector-support-for-political-process 2016-02-02T17:00:01+11:00 https://pharmadispatch.com/news/listing-welcome-but-process-still-a-problem 2016-02-02T17:00:01+11:00 https://pharmadispatch.com/news/humira-continues-to-drive-abbvie-growth 2016-02-02T17:00:01+11:00 https://pharmadispatch.com/news/pbs-not-protected-from-further-savings 2016-02-03T17:00:01+11:00 https://pharmadispatch.com/news/more-change-inside-the-department-of-health 2016-02-03T17:00:01+11:00 https://pharmadispatch.com/news/batch-of-pbs-listed-diuretic-recalled 2016-02-03T17:00:01+11:00 https://pharmadispatch.com/news/pbs-spending-per-person-plummets 2016-02-03T17:00:01+11:00 https://pharmadispatch.com/news/is-the-board-really-the-problem 2016-02-04T17:00:01+11:00 https://pharmadispatch.com/news/no-justification-for-new-savings-says-medicines-partnership 2016-02-04T17:00:01+11:00 https://pharmadispatch.com/news/new-therapy-for-specialised-therapeutics 2016-02-04T17:00:01+11:00 https://pharmadispatch.com/news/make-changes-but-keep-codeine-in-pharmacy-says-asmi 2016-02-04T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-boosted-by-hospira-oncology-and-vaccines 2016-02-04T17:00:01+11:00 https://pharmadispatch.com/news/overwhelming-response-backs-ma-review 2016-02-05T17:00:01+11:00 https://pharmadispatch.com/news/tga-approves-first-asthma-biologic 2016-02-05T17:00:01+11:00 https://pharmadispatch.com/news/new-senior-appointment-for-commercial-eyes 2016-02-05T17:00:01+11:00 https://pharmadispatch.com/news/msd-looks-to-new-therapies 2016-02-05T17:00:01+11:00 https://pharmadispatch.com/news/doubts-remains-as-ministers-sign-tpp 2016-02-05T17:00:01+11:00 https://pharmadispatch.com/news/minister-links-jakavi-listing-to-innovation-agenda 2016-02-05T17:00:01+11:00 https://pharmadispatch.com/news/a-procurement-policy-developing 2016-02-08T17:00:01+11:00 https://pharmadispatch.com/news/sanofi-finalises-new-organisation 2016-02-08T17:00:01+11:00 https://pharmadispatch.com/news/officials-face-senate-questions 2016-02-08T17:00:01+11:00 https://pharmadispatch.com/news/a-year-of-transition-for-az 2016-02-08T17:00:01+11:00 https://pharmadispatch.com/news/department-gets-familiar-with-its-market-power 2016-02-08T17:00:01+11:00 https://pharmadispatch.com/news/uk-recommends-amgens-repatha 2016-02-09T17:00:01+11:00 https://pharmadispatch.com/news/wes-cook-board-seeking-feedback-on-review 2016-02-09T17:06:01+11:00 https://pharmadispatch.com/news/ma-ceo-truly-excited-about-role 2016-02-09T17:00:01+11:00 https://pharmadispatch.com/news/promotion-for-mercks-andre-musto 2016-02-09T17:00:01+11:00 https://pharmadispatch.com/news/ma-and-psa-budget-submissions 2016-02-09T17:00:01+11:00 https://pharmadispatch.com/news/payment-system-needs-to-be-modernised-says-minister 2016-02-10T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-allergan-post-merger-global-leadership 2016-02-10T17:00:01+11:00 https://pharmadispatch.com/news/asmi-calls-for-reform-of-ip 2016-02-10T17:00:01+11:00 https://pharmadispatch.com/news/medicinal-cannabis-legislation-introduced-today 2016-02-10T17:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-baxter 2016-02-11T17:00:01+11:00 https://pharmadispatch.com/news/department-shifts-argument-on-pandaol-osteo 2016-02-11T17:00:01+11:00 https://pharmadispatch.com/news/pbs-schedule-confirms-march-hep-c-listing 2016-02-11T17:00:01+11:00 https://pharmadispatch.com/news/pharmacy-facing-a-challenging-year 2016-02-11T17:00:01+11:00 https://pharmadispatch.com/news/andrew-robb-to-retire-at-election 2016-02-11T17:00:01+11:00 https://pharmadispatch.com/news/anniversary-of-the-meeting-that-changed-everything 2016-02-12T17:00:01+11:00 https://pharmadispatch.com/news/bi-confirms-new-diabetes-listing 2016-02-12T17:00:01+11:00 https://pharmadispatch.com/news/collaboration-on-hcv-therapies-critical 2016-02-12T17:00:01+11:00 https://pharmadispatch.com/news/australian-talent-making-a-difference 2016-02-15T17:00:01+11:00 https://pharmadispatch.com/news/labor-cautious-on-tpp 2016-02-12T17:00:01+11:00 https://pharmadispatch.com/news/ex-gsk-executive-promoted-to-ministry 2016-02-15T17:00:01+11:00 https://pharmadispatch.com/news/ma-rejected-5-compromise-solution 2016-02-15T17:00:01+11:00 https://pharmadispatch.com/news/ex-pfixer-rd-head-joins-la-trobe 2016-02-15T17:00:01+11:00 https://pharmadispatch.com/news/pharmacists-training-to-administer-flu-vax 2016-02-15T17:00:01+11:00 https://pharmadispatch.com/news/shire-focussed-on-integrating-new-assets 2016-02-15T17:00:01+11:00 https://pharmadispatch.com/news/goes-to-work-on-biosimilars 2016-02-16T17:00:01+11:00 https://pharmadispatch.com/news/survival-up-as-cancer-cases-triple 2016-02-16T17:00:01+11:00 https://pharmadispatch.com/news/former-industry-minister-announces-resignation 2016-02-16T17:00:01+11:00 https://pharmadispatch.com/news/companies-get-behind-rare-cancers-climb 2016-02-16T17:00:01+11:00 https://pharmadispatch.com/news/stick-with-australian-products-says-asmi 2016-02-16T17:00:01+11:00 https://pharmadispatch.com/news/a-strong-start-for-csl-in-its-centenary-year 2016-02-17T17:00:01+11:00 https://pharmadispatch.com/news/stakeholder-meetings-long-and-detailed 2016-02-17T17:00:01+11:00 https://pharmadispatch.com/news/nostradata-lacklustre-start-with-more-pain-to-come 2016-02-17T17:00:01+11:00 https://pharmadispatch.com/news/health-set-savings-target 2016-02-17T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-still-searching-for-australian-innovation 2016-02-18T17:00:01+11:00 https://pharmadispatch.com/news/sigma-renews-relationship-with-chemist-warehouse 2016-02-18T17:00:01+11:00 https://pharmadispatch.com/news/delistings-and-higher-patient-costs-inevitable 2016-02-18T17:00:01+11:00 https://pharmadispatch.com/news/breakthrough-designation-for-az-pd-l1 2016-02-18T17:00:01+11:00 https://pharmadispatch.com/news/department-directs-the-playbook-against-device-sector 2016-02-19T17:00:01+11:00 https://pharmadispatch.com/news/new-guidelines-set-for-public-consultation 2016-02-19T17:00:01+11:00 https://pharmadispatch.com/news/australias-new-trade-minister 2016-02-19T17:00:01+11:00 https://pharmadispatch.com/news/sussan-ley-leading-trade-delegation-as-department-strikes 2016-02-22T17:00:01+11:00 https://pharmadispatch.com/news/an-embarrassing-joke-for-sussan-ley-if-it-werent-so-serious 2016-02-22T17:00:01+11:00 https://pharmadispatch.com/news/tga-approves-entresto-as-novartis-signals-pricing-innovation 2016-02-23T05:00:01+11:00 https://pharmadispatch.com/news/industry-concern-over-comparators 2016-02-22T17:00:01+11:00 https://pharmadispatch.com/news/the-extreme-parallel-process 2016-02-22T17:00:01+11:00 https://pharmadispatch.com/news/guild-rejects-co-pay-discount-criticism 2016-02-22T17:00:01+11:00 https://pharmadispatch.com/news/australians-back-pbs-and-oppose-cuts 2016-02-23T17:00:01+11:00 https://pharmadispatch.com/news/consumers-rejecting-pbs-discount 2016-02-23T17:00:01+11:00 https://pharmadispatch.com/news/industry-exec-to-lead-growth-centre 2016-02-23T17:00:01+11:00 https://pharmadispatch.com/news/gsk-brings-researchers-in-house 2016-02-23T17:00:01+11:00 https://pharmadispatch.com/news/more-leadership-change-for-industry 2016-02-23T17:00:01+11:00 https://pharmadispatch.com/news/medical-channel-acquires-medical-media 2016-02-24T16:00:01+11:00 https://pharmadispatch.com/news/ongoing-debate-over-tpp 2016-02-24T16:00:01+11:00 https://pharmadispatch.com/news/give-pharmacy-a-greater-role-guild-tells-inquiry 2016-02-24T16:00:01+11:00 https://pharmadispatch.com/news/new-osteoporosis-therapy-shines-in-study 2016-02-24T16:00:01+11:00 https://pharmadispatch.com/news/bms-confirms-new-gm 2016-02-24T16:00:01+11:00 https://pharmadispatch.com/news/room-with-a-patient-view 2016-02-26T17:00:01+11:00 https://pharmadispatch.com/news/companies-welcome-flu-vax-forum 2016-02-25T17:00:01+11:00 https://pharmadispatch.com/news/investor-boost-for-ebos-after-result 2016-02-25T17:00:01+11:00 https://pharmadispatch.com/news/greens-senator-backs-clinical-trials 2016-02-25T17:00:01+11:00 https://pharmadispatch.com/news/new-campaign-aims-to-raise-awareness-of-home-gp-visits 2016-02-25T17:00:01+11:00 https://pharmadispatch.com/news/minister-set-to-announce-prostheses-reforms 2016-02-26T17:00:01+11:00 https://pharmadispatch.com/news/staff-the-big-winners-from-blackmores-result 2016-02-26T17:00:01+11:00 https://pharmadispatch.com/news/australia-tops-global-pain-index 2016-02-26T17:00:01+11:00 https://pharmadispatch.com/news/australian-groups-win-vertex-cf-grants 2016-02-26T17:00:01+11:00 https://pharmadispatch.com/news/jj-ranked-most-innovative 2016-02-26T17:00:01+11:00 https://pharmadispatch.com/news/industry-gets-behind-pollie-pedal 2016-02-29T17:00:01+11:00 https://pharmadispatch.com/news/mp-backs-patient-push-for-access 2016-02-29T17:00:01+11:00 https://pharmadispatch.com/news/australia-must-protect-its-record-on-access-to-hiv-medicines 2016-02-29T17:00:01+11:00 https://pharmadispatch.com/news/laws-might-need-to-change 2016-02-29T17:00:01+11:00 https://pharmadispatch.com/news/bayer-reports-record-sales-and-calls-on-eu-to-back-innovation 2016-02-29T17:00:01+11:00 https://pharmadispatch.com/news/industry-marks-biggest-ever-pbs-listing 2016-03-01T17:00:01+11:00 https://pharmadispatch.com/news/experts-want-action-on-treatment-rates 2016-03-01T17:00:01+11:00 https://pharmadispatch.com/news/a-watershed-moment-says-sussan-ley 2016-03-01T17:00:01+11:00 https://pharmadispatch.com/news/gallagher-a-tangible-example-of-what-industry-can-do 2016-03-01T17:00:01+11:00 https://pharmadispatch.com/news/tolmar-partners-with-nz-diagnostics-company 2016-03-01T17:00:01+11:00 https://pharmadispatch.com/news/eu-recommends-approval-for-csls-idelvion 2016-03-01T17:00:01+11:00 https://pharmadispatch.com/news/pbs-rebates-set-to-hit-1-billion 2016-03-02T17:00:01+11:00 https://pharmadispatch.com/news/companies-activate-on-new-pbac-guidelines 2016-03-02T17:00:01+11:00 https://pharmadispatch.com/news/senateshj-appoints-new-healthcare-boss 2016-03-02T17:00:01+11:00 https://pharmadispatch.com/news/pcfa-and-anzup-announce-joint-prostate-cancer-fight 2016-03-02T17:00:01+11:00 https://pharmadispatch.com/news/medicine-maze-confusing-for-cancer-patients 2016-03-03T17:00:01+11:00 https://pharmadispatch.com/news/lundbeck-announces-new-australian-leadership 2016-03-02T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-chips-in-to-clean-up-local-environment 2016-03-02T17:00:01+11:00 https://pharmadispatch.com/news/we-must-be-positive-and-pragmatic 2016-03-03T17:00:01+11:00 https://pharmadispatch.com/news/pharmac-faces-growing-criticism 2016-03-03T17:00:01+11:00 https://pharmadispatch.com/news/rebates-hit-by-data-problems 2016-03-03T17:00:01+11:00 https://pharmadispatch.com/news/large-numbers-expected-at-briefing 2016-03-04T17:00:01+11:00 https://pharmadispatch.com/news/greens-shoots-expose-the-reality 2016-03-04T17:00:01+11:00 https://pharmadispatch.com/news/95m-for-over-treatment-study 2016-03-04T17:00:01+11:00 https://pharmadispatch.com/news/australia-takes-centre-stage-at-conference 2016-03-04T17:00:01+11:00 https://pharmadispatch.com/news/five-page-limit-ridiculous 2016-03-07T17:00:01+11:00 https://pharmadispatch.com/news/new-dusc-reports-published 2016-03-07T17:00:01+11:00 https://pharmadispatch.com/news/a-matter-of-interpretation-on-insulin-glargine 2016-03-07T17:00:01+11:00 https://pharmadispatch.com/news/pbac-set-for-significant-meeting 2016-03-07T17:00:01+11:00 https://pharmadispatch.com/news/standing-room-only-for-pbs-reform-briefing 2016-03-07T17:00:01+11:00 https://pharmadispatch.com/news/new-addition-for-maestro 2016-03-08T17:00:01+11:00 https://pharmadispatch.com/news/the-time-is-now-for-social 2016-03-08T17:00:01+11:00 https://pharmadispatch.com/news/health-and-medical-rd-in-top-tier 2016-03-08T17:00:01+11:00 https://pharmadispatch.com/news/gsk-responds-to-tropical-cyclone-winston-in-fiji 2016-03-08T17:00:01+11:00 https://pharmadispatch.com/news/department-drops-five-page-limit 2016-03-08T17:00:01+11:00 https://pharmadispatch.com/news/csl-announces-new-translation-hub-for-melbourne 2016-03-08T17:00:01+11:00 https://pharmadispatch.com/news/industry-groups-back-rd-tax-incentive 2016-03-09T17:00:01+11:00 https://pharmadispatch.com/news/baxalta-focussed-on-innovation 2016-03-09T17:00:01+11:00 https://pharmadispatch.com/news/pharmac-and-the-facts 2016-03-09T17:00:01+11:00 https://pharmadispatch.com/news/shocked-at-the-change-says-cf-patient 2016-03-09T17:00:01+11:00 https://pharmadispatch.com/news/potential-double-dissolution-means-more-uncertainty 2016-03-10T17:00:01+11:00 https://pharmadispatch.com/news/parallel-process-for-orkambi 2016-03-10T17:00:01+11:00 https://pharmadispatch.com/news/emerging-supply-chain-pressures 2016-03-10T17:00:01+11:00 https://pharmadispatch.com/news/immuno-oncology-changing-the-way-companies-operate 2016-03-14T17:00:01+11:00 https://pharmadispatch.com/news/pyne-abbvie-backed-therapy-evidence-of-success 2016-03-10T17:00:01+11:00 https://pharmadispatch.com/news/cook-start-reform-discussions-with-the-outcome-in-mind 2016-03-10T21:00:01+11:00 https://pharmadispatch.com/news/gallagher-infliximab-a-flag-the-right-decision 2016-03-11T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-investment-and-jobs-for-south-australia 2016-03-11T17:00:01+11:00 https://pharmadispatch.com/news/ferris-australia-dead-last-on-collaboration 2016-03-11T17:00:01+11:00 https://pharmadispatch.com/news/patient-groups-back-industry 2016-03-11T17:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-completely-overwhelmed 2016-03-14T17:00:01+11:00 https://pharmadispatch.com/news/industry-contribution-astonishing 2016-03-14T17:00:01+11:00 https://pharmadispatch.com/news/the-pbs-as-a-safety-net 2016-03-14T17:00:01+11:00 https://pharmadispatch.com/news/all-ears-on-sussan-ley 2016-03-14T17:00:01+11:00 https://pharmadispatch.com/news/april-pbs-schedule-update 2016-03-15T17:00:01+11:00 https://pharmadispatch.com/news/at-least-one-empty-chair 2016-03-15T17:00:01+11:00 https://pharmadispatch.com/news/gbma-adds-another-member 2016-03-15T17:00:01+11:00 https://pharmadispatch.com/news/how-low-can-they-go 2016-03-15T17:00:01+11:00 https://pharmadispatch.com/news/government-must-act-on-research-and-access 2016-03-16T17:00:01+11:00 https://pharmadispatch.com/news/az-welcomes-lynparnza-registration 2016-03-16T17:00:01+11:00 https://pharmadispatch.com/news/online-sector-dominates-innovation-and-science-australia-board 2016-03-16T17:00:01+11:00 https://pharmadispatch.com/news/choosing-wisely-issues-latest-recommendations 2016-03-16T17:00:01+11:00 https://pharmadispatch.com/news/could-hardly-have-been-more-different 2016-03-16T17:00:01+11:00 https://pharmadispatch.com/news/health-minister-sussan-leys-speech-to-ma-dinner 2016-03-16T17:00:01+11:00 https://pharmadispatch.com/news/industry-questions-new-pbac-guidelines 2016-03-16T17:00:01+11:00 https://pharmadispatch.com/news/new-zealanders-waiting-too-long 2016-03-17T17:00:01+11:00 https://pharmadispatch.com/news/ma-leaders-commend-associations-new-approach 2016-03-17T03:50:01+11:00 https://pharmadispatch.com/news/us-patent-win-for-amgen 2016-03-17T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-help-me-to-quit 2016-03-22T17:00:01+11:00 https://pharmadispatch.com/news/biosimilars-take-centre-stage-at-app 2016-03-18T03:12:01+11:00 https://pharmadispatch.com/news/a-complete-list 2016-03-18T17:00:01+11:00 https://pharmadispatch.com/news/sector-gives-gives-less-than-positive-assessment 2016-03-18T17:00:01+11:00 https://pharmadispatch.com/news/minister-never-expected-all-pharmacies-to-offer-discount 2016-03-18T17:00:01+11:00 https://pharmadispatch.com/news/fourth-approval-for-opdivo 2016-03-18T17:00:01+11:00 https://pharmadispatch.com/news/should-the-sector-unite-to-deal-with-challenging-times 2016-03-21T17:00:01+11:00 https://pharmadispatch.com/news/minister-announced-pharmacy-trials-without-recommendation 2016-03-21T17:00:01+11:00 https://pharmadispatch.com/news/gbma-very-pleased-with-agreement-and-gmwg 2016-03-21T17:00:01+11:00 https://pharmadispatch.com/news/the-complexity-of-rebates 2016-03-21T17:00:01+11:00 https://pharmadispatch.com/news/paul-spittle-a-time-of-change-and-humility 2016-03-21T17:00:01+11:00 https://pharmadispatch.com/news/the-drug-development-odd-couple 2016-03-21T17:00:01+11:00 https://pharmadispatch.com/news/discounts-remain-an-institutionalised-feature-of-pbs-pricing 2016-03-22T17:00:01+11:00 https://pharmadispatch.com/news/leading-us-lipid-expert-backs-ezetimibe 2016-03-22T17:00:01+11:00 https://pharmadispatch.com/news/early-budget-and-election-means-change 2016-03-22T17:00:01+11:00 https://pharmadispatch.com/news/roche-pbs-reform-means-change 2016-03-23T17:00:01+11:00 https://pharmadispatch.com/news/consideration-of-delivery-charges-a-reality 2016-03-23T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-names-smith-family-their-charity-of-choice-for-2016 2016-03-23T17:00:01+11:00 https://pharmadispatch.com/news/playing-games-on-patent-term-extensions 2016-03-23T17:00:01+11:00 https://pharmadispatch.com/news/the-one-constant-is-change 2016-03-24T17:00:01+11:00 https://pharmadispatch.com/news/sigma-looks-to-hospital-pharmacy 2016-03-24T17:00:01+11:00 https://pharmadispatch.com/news/gsk-consumer-health-celebrates-first-year 2016-03-24T17:00:01+11:00 https://pharmadispatch.com/news/sta-donation-to-international-medical-training 2016-03-24T17:00:01+11:00 https://pharmadispatch.com/news/demand-for-hcv-therapies-incredibly-high 2016-03-29T17:00:01+11:00 https://pharmadispatch.com/news/biosimilar-a-flags-by-inference 2016-03-30T17:00:01+11:00 https://pharmadispatch.com/news/gileads-harvoni-dominates-early-weeks 2016-03-29T17:00:01+11:00 https://pharmadispatch.com/news/diverse-range-of-views-on-community-pharmacy 2016-03-29T17:00:01+11:00 https://pharmadispatch.com/news/msd-wins-hcv-patent-case 2016-03-29T17:00:01+11:00 https://pharmadispatch.com/news/tga-considers-report-on-codeine-combinations 2016-03-29T17:00:01+11:00 https://pharmadispatch.com/news/pcfa-opens-funding-round 2016-03-30T17:00:01+11:00 https://pharmadispatch.com/news/private-equity-acquires-medical-director 2016-03-30T17:00:01+11:00 https://pharmadispatch.com/news/a-rather-glaring-omission-1 2016-03-30T17:00:01+11:00 https://pharmadispatch.com/news/why-ceda-is-wrong 2016-03-31T17:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-gileads-taf-based-regimen-for-hiv 2016-03-31T17:00:01+11:00 https://pharmadispatch.com/news/confused-ceda-proposal-would-eliminate-spending-on-generics 2016-03-31T17:00:01+11:00 https://pharmadispatch.com/news/vertex-secures-wider-tga-approval-for-kalydeco 2016-03-31T17:00:01+11:00 https://pharmadispatch.com/news/nz-highest-melanoma-rates-and-worst-access-1 2016-03-31T17:00:01+11:00 https://pharmadispatch.com/news/government-set-to-announce-chronic-health-reform 2016-03-31T17:00:01+11:00 https://pharmadispatch.com/news/soriot-if-sweden-does-it-why-cant-australia 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/leading-a-company-in-transition-1 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/companies-will-cut-rd-spending 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/pat-clear-award-goes-to-long-serving-msd-exec 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/include-pharmacy-in-health-care-home 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/industry-critic-questions-guidelines-development 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/bms-hiv-combination-pbs-listed-from-today 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/more-positive-news-for-specialised-therapeutics 2016-04-01T17:00:01+11:00 https://pharmadispatch.com/news/gsk-to-drop-patents-in-poorest-countries 2016-04-04T16:00:01+10:00 https://pharmadispatch.com/news/budget-important-not-just-because-of-the-measures 2016-04-04T16:00:01+10:00 https://pharmadispatch.com/news/spend-what-is-budgeted-says-sigmas-mark-hooper 2016-04-04T16:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-coag-focus-on-avoidance 2016-04-04T16:00:01+10:00 https://pharmadispatch.com/news/price-cuts-flow-through-to-private-market 2016-04-04T16:00:01+10:00 https://pharmadispatch.com/news/biointelect-acquired-by-biotech-capital 2016-04-05T16:00:01+10:00 https://pharmadispatch.com/news/carlo-montagner-innovation-will-suffer 2016-04-05T16:00:01+10:00 https://pharmadispatch.com/news/unprecedented-commercial-challenge 2016-04-05T16:00:01+10:00 https://pharmadispatch.com/news/baxter-increases-use-of-clean-power 2016-04-05T16:00:01+10:00 https://pharmadispatch.com/news/professor-ian-frazer-to-chair-mrff-advisory-group 2016-04-05T16:00:01+10:00 https://pharmadispatch.com/news/acknowledge-medicines-sector 2016-04-05T16:00:01+10:00 https://pharmadispatch.com/news/health-struggling-as-budget-nears 2016-04-06T16:00:01+10:00 https://pharmadispatch.com/news/pbac-exempted-just-six-combinations-from-1-april-price-cuts-so-f 2016-04-06T16:00:01+10:00 https://pharmadispatch.com/news/new-cholesterol-lowering-biologics-headline-cardiology-meeting 2016-04-06T16:00:01+10:00 https://pharmadispatch.com/news/new-tax-rules-threaten-pfizer-allergan-deal 2016-04-06T16:00:01+10:00 https://pharmadispatch.com/news/positive-study-result-for-bayers-xarelto 2016-04-06T16:00:01+10:00 https://pharmadispatch.com/news/new-treatment-to-help-gps-face-up-to-rosacea 2016-04-06T16:00:01+10:00 https://pharmadispatch.com/news/industry-nominated-pbac-member 2016-04-07T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-teams-up-with-experts-on-flu-resource 2016-04-07T16:00:01+10:00 https://pharmadispatch.com/news/the-gift-that-keeps-on-giving-1 2016-04-07T16:00:01+10:00 https://pharmadispatch.com/news/department-confirms-co-payment-discount-uptake 2016-04-07T16:00:01+10:00 https://pharmadispatch.com/news/speculation-pfizer-could-pursue-another-takeover 2016-04-07T16:00:01+10:00 https://pharmadispatch.com/news/did-it-really-deserve-that-response 2016-04-08T16:00:01+10:00 https://pharmadispatch.com/news/scrapped-merger-sparks-tax-debate 2016-04-08T16:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-government-wrong-on-incentive 2016-04-08T16:00:01+10:00 https://pharmadispatch.com/news/are-generics-really-new-medicines 2016-04-08T16:00:01+10:00 https://pharmadispatch.com/news/gbma-biosimilar-benefits-no-longer-theoretical 2016-04-08T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-ceo-slams-us-tax-changes 2016-04-11T16:00:01+10:00 https://pharmadispatch.com/news/not-enough-being-done-to-stimulate-medical-innovation 2016-04-11T16:00:01+10:00 https://pharmadispatch.com/news/progress-for-alzheimers-therapies 2016-04-11T16:00:01+10:00 https://pharmadispatch.com/news/department-companies-have-raised-delisting-concerns 2016-04-11T16:00:01+10:00 https://pharmadispatch.com/news/new-resource-for-parkinsons-disease 2016-04-11T16:00:01+10:00 https://pharmadispatch.com/news/values-arent-just-words-on-the-wall 2016-04-11T16:00:01+10:00 https://pharmadispatch.com/news/first-meeting-of-biosimilar-awareness-reference-group 2016-04-12T16:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-commitment-of-health-ministers 2016-04-12T16:00:01+10:00 https://pharmadispatch.com/news/health-ministers-recognition 2016-04-12T16:00:01+10:00 https://pharmadispatch.com/news/blackmores-hit-as-china-changes-take-effect 2016-04-12T16:00:01+10:00 https://pharmadispatch.com/news/ma-progressing-ceo-hunt 2016-04-13T16:00:01+10:00 https://pharmadispatch.com/news/devil-in-the-budget-detail 2016-04-13T16:00:01+10:00 https://pharmadispatch.com/news/viiv-announced-positive-action-community-grants 2016-04-13T16:00:01+10:00 https://pharmadispatch.com/news/treasury-confirms-mrff-hole 2016-04-13T16:00:01+10:00 https://pharmadispatch.com/news/accc-seeks-6m-fine-over-nurofen 2016-04-13T16:00:01+10:00 https://pharmadispatch.com/news/gsk-to-pursue-wider-listing-for-volibris 2016-04-14T16:00:01+10:00 https://pharmadispatch.com/news/apotex-pulls-products-as-reforms-hit 2016-04-13T21:42:01+10:00 https://pharmadispatch.com/news/measuring-the-true-cost-of-the-pbs 2016-04-14T16:00:01+10:00 https://pharmadispatch.com/news/gbma-the-mechanism-is-failing 2016-04-14T16:00:01+10:00 https://pharmadispatch.com/news/200-facing-new-price-disclosure-rules 2016-04-14T16:00:01+10:00 https://pharmadispatch.com/news/the-search-for-a-ceo-takes-the-next-step 2016-04-15T16:00:01+10:00 https://pharmadispatch.com/news/lee-hill-this-is-a-very-exciting-opportunity 2016-04-15T16:00:01+10:00 https://pharmadispatch.com/news/department-moves-to-delist-popular-blood-pressure-combination 2016-04-15T16:00:01+10:00 https://pharmadispatch.com/news/implement-tppa-requirements-medicines-nz-tells-government 2016-04-15T16:00:01+10:00 https://pharmadispatch.com/news/consider-the-principle-not-the-product 2016-04-15T16:00:01+10:00 https://pharmadispatch.com/news/csl-announces-rd-support-program 2016-04-18T16:00:01+10:00 https://pharmadispatch.com/news/abbvie-welcomes-1-may-hcv-listing 2016-04-18T16:00:01+10:00 https://pharmadispatch.com/news/spittle-the-right-thing-to-do 2016-04-18T16:00:01+10:00 https://pharmadispatch.com/news/hcv-sales-soar-in-march 2016-04-19T16:00:01+10:00 https://pharmadispatch.com/news/andrew-wilson-an-exciting-time-to-be-pbac-chair 2016-04-18T16:00:01+10:00 https://pharmadispatch.com/news/valeant-looks-to-divest-assets 2016-04-18T16:00:01+10:00 https://pharmadispatch.com/news/andrew-wilson-pbac-is-constantly-evolving 2016-04-19T16:00:01+10:00 https://pharmadispatch.com/news/jannsen-welcomes-ribomustin-listing 2016-04-19T16:00:01+10:00 https://pharmadispatch.com/news/low-ranking-for-australia-in-new-innovation-report 2016-04-19T16:00:01+10:00 https://pharmadispatch.com/news/az-considers-bid-for-medivation 2016-04-19T16:00:01+10:00 https://pharmadispatch.com/news/sector-faces-the-reality-of-early-election 2016-04-19T16:00:01+10:00 https://pharmadispatch.com/news/government-does-well-by-shifting-risk 2016-04-20T16:00:01+10:00 https://pharmadispatch.com/news/the-pbs-debate-could-be-about-to-change 2016-04-20T16:00:01+10:00 https://pharmadispatch.com/news/bayer-team-back-winning-hackathon-idea 2016-04-20T16:00:01+10:00 https://pharmadispatch.com/news/prep-approval-moving-closer 2016-04-20T16:00:01+10:00 https://pharmadispatch.com/news/company-results-roche 2016-04-20T16:00:01+10:00 https://pharmadispatch.com/news/ma-vigorously-opposes-comparator-change 2016-04-21T16:00:01+10:00 https://pharmadispatch.com/news/patients-are-technical-experts 2016-04-21T16:00:01+10:00 https://pharmadispatch.com/news/guild-wants-new-hcv-model 2016-04-21T16:00:01+10:00 https://pharmadispatch.com/news/estimates-in-phoney-election-campaign 2016-04-21T16:00:01+10:00 https://pharmadispatch.com/news/bi-highlights-rd-investment 2016-04-21T16:00:01+10:00 https://pharmadispatch.com/news/csl-sticks-with-ma 2016-04-22T16:00:01+10:00 https://pharmadispatch.com/news/us-calls-australia-and-nz-on-trade-games 2016-04-22T16:00:01+10:00 https://pharmadispatch.com/news/priceline-retail-transforming-api 2016-04-22T16:00:01+10:00 https://pharmadispatch.com/news/progress-for-industry-working-groups 2016-04-22T16:00:01+10:00 https://pharmadispatch.com/news/novartis-investing-in-new-products 2016-04-22T16:00:01+10:00 https://pharmadispatch.com/news/two-more-post-market-reviews-2 2016-04-23T01:26:01+10:00 https://pharmadispatch.com/news/pbac-says-no-to-ivf-biosimilar 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/government-wins-as-staggering-hcv-uptake-continues-to-soar 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/pbac-sticks-by-panadol-osteo-decision 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/vertex-will-try-again-on-orkambi 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/csl-marks-official-centenary 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/senate-bluster-not-backed-by-any-recommendations 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-march-pbac-outcomes 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/outcome-raises-concern-of-future-of-managed-entry 2016-04-26T16:00:01+10:00 https://pharmadispatch.com/news/an-important-week-for-ma-against-a-confusing-backdrop 2016-04-27T16:00:01+10:00 https://pharmadispatch.com/news/new-strategic-plan-for-medicines-nz 2016-04-27T16:00:01+10:00 https://pharmadispatch.com/news/novartis-considering-sale-of-roche-stake 2016-04-27T16:00:01+10:00 https://pharmadispatch.com/news/tolmar-anzup-uro-oncology-clinical-research-fellowship-2016 2016-04-27T16:00:01+10:00 https://pharmadispatch.com/news/new-products-boost-lilly 2016-04-27T16:00:01+10:00 https://pharmadispatch.com/news/comparator-pricing-undermining-formulary-split 2016-04-28T16:00:01+10:00 https://pharmadispatch.com/news/infliximab-price-starting-to-bite-bdmards 2016-04-28T16:00:01+10:00 https://pharmadispatch.com/news/lowest-first-quarter-cpi-drug-price-rise-in-two-decades 2016-04-28T16:00:01+10:00 https://pharmadispatch.com/news/senior-australians-missing-immunisations 2016-04-28T16:00:01+10:00 https://pharmadispatch.com/news/ma-marks-world-ip-day 2016-04-28T16:00:01+10:00 https://pharmadispatch.com/news/bayer-reports-strong-profit-growth 2016-04-28T16:00:01+10:00 https://pharmadispatch.com/news/breaking-political-rules-in-health 2016-05-03T16:00:01+10:00 https://pharmadispatch.com/news/australian-researchers-identify-vitamin-d-ms-link 2016-04-29T16:00:01+10:00 https://pharmadispatch.com/news/seeing-red-for-ms 2016-04-29T16:00:01+10:00 https://pharmadispatch.com/news/substitution-gets-real-with-msds-etanercept 2016-04-29T16:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-significant-new-listings-in-july 2016-04-29T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-makes-takeover-bid-for-medivation 2016-04-29T16:00:01+10:00 https://pharmadispatch.com/news/new-ebook-offers-guidance-on-managing-reputation 2016-04-29T16:00:01+10:00 https://pharmadispatch.com/news/blackmores-profit-still-soaring 2016-04-29T16:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-calls-for-pharma-ip-changes 2016-04-29T19:21:01+10:00 https://pharmadispatch.com/news/on-q-recruitment-salary-and-job-satisfaction-survey-in-its-tenth 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/company-results-amgen-abbvie-bms-az-gilead-celgene-and-ipsen 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/another-impractical-report-on-ip 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/the-first-listing-of-many-for-bms-opdivo 2016-05-03T00:29:01+10:00 https://pharmadispatch.com/news/sector-responds-to-productivity-commission-ip-report 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/special-mention-in-us-trade-report 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/major-deals-for-abbvie-and-abbott-as-sanofi-pushes-on-medivation 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/accc-could-appeal-nurofen-fine 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/gsk-partnership-leads-to-major-breakthrough-for-newborns-in-deve 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/code-of-conduct-determinations 2016-05-02T16:00:01+10:00 https://pharmadispatch.com/news/the-world-has-changed 2016-05-12T16:00:01+10:00 https://pharmadispatch.com/news/patients-devastated-by-orkambi-rejection 2016-05-03T16:00:01+10:00 https://pharmadispatch.com/news/the-field-is-starting-to-explode 2016-05-03T16:00:01+10:00 https://pharmadispatch.com/news/viiv-and-change-headline-gsks-2015-result 2016-05-03T16:00:01+10:00 https://pharmadispatch.com/news/comparator-concern-for-mental-health-groups 2016-05-03T16:00:01+10:00 https://pharmadispatch.com/news/no-new-savings-but-price-disclosure-savings-forecast-to-hit-20-b 2016-05-04T05:30:01+10:00 https://pharmadispatch.com/news/budget-2016-17-the-measures 2016-05-04T05:30:01+10:00 https://pharmadispatch.com/news/abbvie-offers-pharmacy-hcv-relief 2016-05-04T16:00:01+10:00 https://pharmadispatch.com/news/something-quite-odd 2016-05-05T04:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-no-surprises-budget 2016-05-04T16:00:01+10:00 https://pharmadispatch.com/news/new-products-and-hospira-boost-pfizer 2016-05-04T16:00:01+10:00 https://pharmadispatch.com/news/time-to-hand-over-your-phone 2016-05-05T16:00:01+10:00 https://pharmadispatch.com/news/why-the-forecast-is-important 2016-05-05T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-considers-its-own-move-for-medivation 2016-05-05T16:00:01+10:00 https://pharmadispatch.com/news/extra-money-for-pharmac 2016-05-05T16:00:01+10:00 https://pharmadispatch.com/news/sector-calls-for-certainty-and-predictability 2016-05-05T16:00:01+10:00 https://pharmadispatch.com/news/official-report-confirms-fall-in-pbs-spend 2016-05-05T16:00:01+10:00 https://pharmadispatch.com/news/jj-medical-boost-for-indigenous-doctors 2016-05-05T16:00:01+10:00 https://pharmadispatch.com/news/taking-the-right-option 2016-05-06T16:00:01+10:00 https://pharmadispatch.com/news/spending-shift-from-f2-to-f1 2016-05-06T16:00:01+10:00 https://pharmadispatch.com/news/gbma-welcomes-budget-certainty 2016-05-06T16:00:01+10:00 https://pharmadispatch.com/news/keytruda-delivers-for-msd-in-first-quarter 2016-05-06T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-talks-tough-on-medivation 2016-05-06T16:24:01+10:00 https://pharmadispatch.com/news/one-minute-for-pbs-at-estimates 2016-05-09T16:00:01+10:00 https://pharmadispatch.com/news/pm-calls-election-as-sector-faces-long-caretaker-period 2016-05-08T20:48:01+10:00 https://pharmadispatch.com/news/questions-over-lack-of-transparency 2016-05-09T16:00:01+10:00 https://pharmadispatch.com/news/experts-unite-over-revised-pbac-guidelines 2016-05-09T16:00:01+10:00 https://pharmadispatch.com/news/greens-want-truvada-listed-for-prep 2016-05-09T16:00:01+10:00 https://pharmadispatch.com/news/incredible-transformation-in-drug-development 2016-05-09T16:00:01+10:00 https://pharmadispatch.com/news/health-and-pbs-likely-features-of-a-long-campaign 2016-05-09T16:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-looking-for-leaders 2016-05-09T16:00:01+10:00 https://pharmadispatch.com/news/uncertainty-for-1-july-listings 2016-05-10T16:00:01+10:00 https://pharmadispatch.com/news/no-direction-not-to-publish 2016-05-10T16:00:01+10:00 https://pharmadispatch.com/news/eary-political-backing-for-pharmacy 2016-05-10T16:00:01+10:00 https://pharmadispatch.com/news/tga-review-to-deliver-red-tape-savings 2016-05-10T16:00:01+10:00 https://pharmadispatch.com/news/medivation-succumbs-to-pressure 2016-05-10T16:00:01+10:00 https://pharmadispatch.com/news/distorted-picture-of-pbs-spend 2016-05-11T16:00:01+10:00 https://pharmadispatch.com/news/leaders-take-different-paths-on-health 2016-05-11T16:00:01+10:00 https://pharmadispatch.com/news/improvements-in-cv-health-drive-reduction-in-overall-burden-of-d 2016-05-11T16:00:01+10:00 https://pharmadispatch.com/news/health-funds-still-favour-natural-therapies-over-medicines 2016-05-11T16:00:01+10:00 https://pharmadispatch.com/news/final-approval-for-pharmacy-delivered-vaccinations-in-victoria 2016-05-11T16:00:01+10:00 https://pharmadispatch.com/news/racgp-endorses-clinical-prostate-test-guidelines 2016-05-11T16:00:01+10:00 https://pharmadispatch.com/news/the-7-drivers-of-corporate-reputation 2016-05-12T16:00:01+10:00 https://pharmadispatch.com/news/senior-australians-underestimating-risks 2016-05-12T16:00:01+10:00 https://pharmadispatch.com/news/do-the-caretaker-conventions-really-apply 2016-05-11T23:12:01+10:00 https://pharmadispatch.com/news/promotion-for-ex-pbac-chair 2016-05-12T16:00:01+10:00 https://pharmadispatch.com/news/hep-c-sales-hit-half-a-billion-in-just-nine-weeks 2016-05-13T16:00:01+10:00 https://pharmadispatch.com/news/bi-welcomes-approval-of-first-noac-reversal-agent 2016-05-13T16:00:01+10:00 https://pharmadispatch.com/news/european-approval-for-csls-idelvion 2016-05-13T16:00:01+10:00 https://pharmadispatch.com/news/bayer-backing-for-new-stroke-resource 2016-05-13T16:00:01+10:00 https://pharmadispatch.com/news/the-focus-shifts-to-f1-as-pbs-spending-gives-the-appearance-of-a 2016-05-13T16:00:01+10:00 https://pharmadispatch.com/news/australian-alliance-supporting-pacific-during-el-nio 2016-05-16T16:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-better-contraception-support 2016-05-15T01:34:01+10:00 https://pharmadispatch.com/news/telstra-health-to-develop-and-operate-national-cancer-screening- 2016-05-16T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-moves-against-medivation-board 2016-05-16T16:00:01+10:00 https://pharmadispatch.com/news/research-reveals-low-awareness 2016-05-17T16:00:01+10:00 https://pharmadispatch.com/news/coalition-shuts-down-pathology-problem 2016-05-16T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-says-no-to-us-executing-states 2016-05-16T16:00:01+10:00 https://pharmadispatch.com/news/a-questionable-victory 2016-05-16T16:00:01+10:00 https://pharmadispatch.com/news/wider-access-to-continuous-glucose-monitoring 2016-05-16T16:00:01+10:00 https://pharmadispatch.com/news/novartis-copd-therapy-shows-superiority-in-trial 2016-05-17T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-negotiation-not-confrontation 2016-05-17T16:00:01+10:00 https://pharmadispatch.com/news/report-claims-codeine-misuse-still-a-problem 2016-05-17T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-acquires-anacor-for-us52bn 2016-05-17T16:00:01+10:00 https://pharmadispatch.com/news/just-1-in-8-drugs-make-it-to-market 2016-05-18T16:00:01+10:00 https://pharmadispatch.com/news/prima-biomed-find-immunotherapy-partner 2016-05-18T16:00:01+10:00 https://pharmadispatch.com/news/structural-change-as-novartis-elevates-oncology 2016-05-18T16:00:01+10:00 https://pharmadispatch.com/news/the-long-battle-for-f1-gets-underway 2016-05-18T16:00:01+10:00 https://pharmadispatch.com/news/complementary-medicines-sector-slams-abc 2016-05-19T16:00:01+10:00 https://pharmadispatch.com/news/election-result-could-be-messy 2016-05-20T16:00:01+10:00 https://pharmadispatch.com/news/bayer-symbions-supplier-of-the-year 2016-05-19T16:00:01+10:00 https://pharmadispatch.com/news/novartis-halts-trial-after-positive-results 2016-05-19T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-responds-to-listing-request 2016-05-19T16:00:01+10:00 https://pharmadispatch.com/news/labor-moves-on-health 2016-05-19T15:00:01+10:00 https://pharmadispatch.com/news/bayer-makes-move-for-monsanto 2016-05-20T16:00:01+10:00 https://pharmadispatch.com/news/coalition-commits-to-clinical-trials 2016-05-20T16:00:01+10:00 https://pharmadispatch.com/news/gsk-recalls-three-batches-of-childrens-panadol 2016-05-21T04:00:01+10:00 https://pharmadispatch.com/news/industry-should-pay-for-antibiotic-incentive 2016-05-20T16:00:01+10:00 https://pharmadispatch.com/news/greens-will-ignore-pbac-on-prep 2016-05-23T16:00:01+10:00 https://pharmadispatch.com/news/greens-back-support-for-collaborations-and-commercialisation 2016-05-23T16:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-coalitions-commitment-on-clinical-trials 2016-05-23T16:00:01+10:00 https://pharmadispatch.com/news/pbs-dominates-election-sunday 2016-05-23T16:00:01+10:00 https://pharmadispatch.com/news/a-strange-day-topped-by-greens-pbac-stance 2016-05-23T16:00:01+10:00 https://pharmadispatch.com/news/a-match-made-in-heaven 2016-05-25T16:00:01+10:00 https://pharmadispatch.com/news/central-agencies-control-health-spendingsurprise-surprise 2016-05-24T16:00:01+10:00 https://pharmadispatch.com/news/labor-coalition-health-policy-in-tatters 2016-05-24T16:00:01+10:00 https://pharmadispatch.com/news/bayer-confirms-us62bn-bid-for-monsanto 2016-05-24T16:00:01+10:00 https://pharmadispatch.com/news/more-needs-to-be-done-says-rare-cancers 2016-05-24T16:00:01+10:00 https://pharmadispatch.com/news/accc-confirms-nurofen-appeal 2016-05-24T16:00:01+10:00 https://pharmadispatch.com/news/locally-developed-option 2016-05-24T16:00:01+10:00 https://pharmadispatch.com/news/biosimilar-stakeholder-forum-moves-one-step-closer 2016-05-25T16:00:01+10:00 https://pharmadispatch.com/news/early-results-from-on-q-recruitment-salary-and-job-satisfaction- 2016-05-25T16:00:01+10:00 https://pharmadispatch.com/news/generics-and-restriction-changes-for-1-june 2016-05-25T16:00:01+10:00 https://pharmadispatch.com/news/us-approval-for-seqirus-qiv 2016-05-25T16:00:01+10:00 https://pharmadispatch.com/news/monsanto-spurns-bayer-but-open-to-more-talks 2016-05-25T16:00:01+10:00 https://pharmadispatch.com/news/arrow-pharmas-leon-moore-talks-transition 2016-06-01T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-pushing-on-with-medivation-bid 2016-05-26T16:00:01+10:00 https://pharmadispatch.com/news/medicare-catching-up-on-hcv-therapies 2016-05-26T16:00:01+10:00 https://pharmadispatch.com/news/get-in-front-of-this-issue-before-its-too-late 2016-05-26T16:00:01+10:00 https://pharmadispatch.com/news/real-time-reporting-must-be-a-high-priority-says-psa 2016-05-26T16:00:01+10:00 https://pharmadispatch.com/news/labor-keeping-health-front-and-centre 2016-05-26T16:00:01+10:00 https://pharmadispatch.com/news/pbs-spikes-on-hcv-and-cancer-spending 2016-05-27T16:00:01+10:00 https://pharmadispatch.com/news/another-us-approval-for-csl 2016-05-27T16:00:01+10:00 https://pharmadispatch.com/news/ex-sigma-execs-avoid-custodial-sentence 2016-05-27T16:00:01+10:00 https://pharmadispatch.com/news/australians-rate-industry-according-to-new-analysis 2016-05-27T16:00:01+10:00 https://pharmadispatch.com/news/tga-releases-performance-snapshot 2016-05-27T16:00:01+10:00 https://pharmadispatch.com/news/15-billion-in-lost-revenue-if-current-skills-gap-left-to-widen 2016-05-27T16:06:01+10:00 https://pharmadispatch.com/news/teva-pharma-pursuing-innovation-in-australia 2016-05-30T16:00:01+10:00 https://pharmadispatch.com/news/caretaker-starts-to-impact-listings 2016-05-30T16:00:01+10:00 https://pharmadispatch.com/news/still-concerns-about-the-bigger-picture 2016-05-30T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-wanting-a-devils-bargain-on-medivation 2016-05-30T16:00:01+10:00 https://pharmadispatch.com/news/pbs-spending-shifting-to-hospital 2016-05-30T16:00:01+10:00 https://pharmadispatch.com/news/new-senior-appointments-for-research-australia 2016-05-30T16:00:01+10:00 https://pharmadispatch.com/news/shire-baxalta-merger-expected-to-close-this-week 2016-05-31T16:00:01+10:00 https://pharmadispatch.com/news/ma-continues-search-for-new-ceo 2016-05-31T16:00:01+10:00 https://pharmadispatch.com/news/another-biosimilar-gets-the-nod-in-eu 2016-05-31T16:00:01+10:00 https://pharmadispatch.com/news/abbott-launches-new-glucose-monitoring-system 2016-06-01T16:00:01+10:00 https://pharmadispatch.com/news/coalition-targets-childhood-cancers 2016-06-01T16:00:01+10:00 https://pharmadispatch.com/news/priceline-launches-next-generation-store 2016-06-01T16:00:01+10:00 https://pharmadispatch.com/news/baxter-inks-chemo-compounding-deal-with-ramsay 2016-06-01T16:00:01+10:00 https://pharmadispatch.com/news/biotech-leaders-optimistic-but-concerned-for-future-of-rd-tax-in 2016-06-01T16:00:01+10:00 https://pharmadispatch.com/news/clinicians-welcome-prescribing-change 2016-06-02T16:00:01+10:00 https://pharmadispatch.com/news/pbs-for-janssens-stelara 2016-06-02T16:00:01+10:00 https://pharmadispatch.com/news/applications-open-for-csl-fellowship 2016-06-02T16:00:01+10:00 https://pharmadispatch.com/news/new-budget-analysis-confirms-pbs-spend-challenge 2016-06-02T16:00:01+10:00 https://pharmadispatch.com/news/abstracts-now-open-for-gptec2016 2016-06-02T16:00:01+10:00 https://pharmadispatch.com/news/time-to-get-serious-about-patient-input 2016-06-03T16:00:01+10:00 https://pharmadispatch.com/news/80m-collaboration-launched-to-discover-new-medicines 2016-06-03T16:00:01+10:00 https://pharmadispatch.com/news/another-three-months-for-lee-hill-at-ma 2016-06-03T16:00:01+10:00 https://pharmadispatch.com/news/coalition-raises-spectre-of-deferrals-in-xolair-listing 2016-06-03T16:00:01+10:00 https://pharmadispatch.com/news/gbma-marks-first-year-of-strategic-agreement 2016-06-03T16:00:01+10:00 https://pharmadispatch.com/news/the-sectors-only-friends-as-things-get-tougher 2016-06-06T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-sill-interested-in-mega-mergers 2016-06-06T16:00:01+10:00 https://pharmadispatch.com/news/specialists-key-to-biosimilar-uptake 2016-06-06T16:00:01+10:00 https://pharmadispatch.com/news/tga-moves-to-increase-transparency 2016-06-06T16:00:01+10:00 https://pharmadispatch.com/news/shire-completes-baxalta-acquisition 2016-06-06T16:00:01+10:00 https://pharmadispatch.com/news/chf-releases-election-platform 2016-06-07T16:00:01+10:00 https://pharmadispatch.com/news/positive-trial-results-for-pfizers-ibrance 2016-06-07T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-pfizer-australia 2016-06-07T16:00:01+10:00 https://pharmadispatch.com/news/strong-backing-for-pharmacy-from-pm 2016-06-07T16:00:01+10:00 https://pharmadispatch.com/news/seqirus-donates-flu-vax-to-fiji 2016-06-07T16:00:01+10:00 https://pharmadispatch.com/news/mrff-should-fund-research-into-complementary-meds-says-asmi 2016-06-07T16:00:01+10:00 https://pharmadispatch.com/news/july-pbs-schedule-reflects-caretaker-impact 2016-06-08T16:00:01+10:00 https://pharmadispatch.com/news/ma-productivity-commission-does-not-understand-pharma-ip 2016-06-08T16:00:01+10:00 https://pharmadispatch.com/news/aamri-says-funding-for-the-full-spectrum-essential 2016-06-08T16:00:01+10:00 https://pharmadispatch.com/news/us-judge-overturns-hep-c-patent-case 2016-06-08T16:00:01+10:00 https://pharmadispatch.com/news/health-idc-on-pbs-but-was-it-the-only-one 2016-06-09T16:00:01+10:00 https://pharmadispatch.com/news/guild-secures-more-support-for-pharmacy 2016-06-09T16:00:01+10:00 https://pharmadispatch.com/news/maybe-pharma-secures-us-approval 2016-06-09T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-wants-medivation-board-gone-by-1-august 2016-06-09T16:00:01+10:00 https://pharmadispatch.com/news/the-reference-that-gave-away-the-second-idc 2016-06-10T16:00:01+10:00 https://pharmadispatch.com/news/why-is-this-so-important 2016-06-10T16:00:01+10:00 https://pharmadispatch.com/news/nz-funds-opdivo-from-1-july 2016-06-10T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-pasteur-calls-for-bright-ideas 2016-06-10T16:00:01+10:00 https://pharmadispatch.com/news/been-here-before-says-ausbiotech-on-ip-report 2016-06-10T16:00:01+10:00 https://pharmadispatch.com/news/labor-scraps-opposition-to-rd-tax-cut 2016-06-14T16:00:01+10:00 https://pharmadispatch.com/news/queens-birthday-honours-for-key-pharma-figures 2016-06-14T16:00:01+10:00 https://pharmadispatch.com/news/recognition-for-csl-manufacturing-facility 2016-06-14T16:00:01+10:00 https://pharmadispatch.com/news/symbion-keeps-delivering-through-tasmanian-floods 2016-06-14T16:00:01+10:00 https://pharmadispatch.com/news/blackmores-makes-it-into-top-100 2016-06-14T16:00:01+10:00 https://pharmadispatch.com/news/new-data-on-biosimilars 2016-06-14T16:00:01+10:00 https://pharmadispatch.com/news/next-step-for-sanofi-in-medivation-takeover 2016-06-15T16:00:01+10:00 https://pharmadispatch.com/news/standoff-between-bayer-and-monsanto 2016-06-15T16:00:01+10:00 https://pharmadispatch.com/news/vertex-proposes-early-access-arrangement 2016-06-15T16:00:01+10:00 https://pharmadispatch.com/news/blow-for-leading-australian-biotech 2016-06-15T16:00:01+10:00 https://pharmadispatch.com/news/trial-shows-cv-benefit-of-novo-nordisks-victoza 2016-06-15T16:00:01+10:00 https://pharmadispatch.com/news/different-approach-required-for-new-cancer-therapies 2016-06-20T16:00:01+10:00 https://pharmadispatch.com/news/shire-local-leadership-confirmed 2016-06-16T16:00:01+10:00 https://pharmadispatch.com/news/pharmacy-clean-sweep-with-labor-backing 2016-06-16T16:00:01+10:00 https://pharmadispatch.com/news/labor-outguns-coalition-on-diabetes-commitment 2016-06-16T16:00:01+10:00 https://pharmadispatch.com/news/labor-to-increase-penalties-for-misleading-claims 2016-06-16T16:00:01+10:00 https://pharmadispatch.com/news/grattan-does-it-again 2016-06-16T04:23:01+10:00 https://pharmadispatch.com/news/positive-renal-data-for-pbs-listed-jardiance 2016-06-16T16:00:01+10:00 https://pharmadispatch.com/news/winners-of-jj-innovation-quickfire-challenge 2016-06-16T16:00:01+10:00 https://pharmadispatch.com/news/roundtable-on-pharmaceutical-patents 2016-06-17T16:00:01+10:00 https://pharmadispatch.com/news/gbma-biosimilar-policy-discussion-has-evolved 2016-06-17T16:00:01+10:00 https://pharmadispatch.com/news/victorian-government-backs-new-manufacturing-facility 2016-06-17T16:00:01+10:00 https://pharmadispatch.com/news/a-pointless-exercise-that-only-harms-australia 2016-06-17T16:00:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-ip-the-productivity-commission-might-give-the-u 2016-06-20T16:00:01+10:00 https://pharmadispatch.com/news/still-waiting-for-lsdp-report 2016-06-20T16:00:01+10:00 https://pharmadispatch.com/news/biosimilar-forum-set-for-later-this-week 2016-06-21T16:00:01+10:00 https://pharmadispatch.com/news/recognition-for-janssen-mental-health-campaign 2016-06-20T16:00:01+10:00 https://pharmadispatch.com/news/coalition-scraps-payment-outsourcing-plan 2016-06-20T16:00:01+10:00 https://pharmadispatch.com/news/labor-we-wont-smash-an-industry-were-trying-to-build 2016-06-21T16:00:01+10:00 https://pharmadispatch.com/news/first-pharmacist-administered-vaccine-in-victoria 2016-06-21T16:00:01+10:00 https://pharmadispatch.com/news/caretaker-could-delay-notification-of-1-october-price-cuts 2016-06-21T16:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-starts-ip-hearings 2016-06-21T16:00:01+10:00 https://pharmadispatch.com/news/government-advice-confirmed-trade-reality 2016-06-22T16:00:01+10:00 https://pharmadispatch.com/news/sector-goes-head-to-head-at-ip-hearing 2016-06-22T16:00:01+10:00 https://pharmadispatch.com/news/some-are-hard-to-please-on-pbs-pricing 2016-06-22T16:00:01+10:00 https://pharmadispatch.com/news/key-role-for-pharmacists-in-managing-antibiotic-use 2016-06-22T16:00:01+10:00 https://pharmadispatch.com/news/ndss-changes-an-opportunity-for-pharmacy 2016-06-22T16:00:01+10:00 https://pharmadispatch.com/news/australian-officials-already-talking-down-ip-report 2016-06-23T16:00:01+10:00 https://pharmadispatch.com/news/wider-indication-but-frustration-for-biogen 2016-06-23T16:00:01+10:00 https://pharmadispatch.com/news/the-changes-keep-coming 2016-06-23T16:00:01+10:00 https://pharmadispatch.com/news/grattan-asks-for-donations 2016-06-23T16:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-missing-the-point-on-ip 2016-06-24T01:11:01+10:00 https://pharmadispatch.com/news/new-study-backs-early-use-of-novartis-heart-failure-therapy 2016-06-24T16:00:01+10:00 https://pharmadispatch.com/news/joe-demarte-re-elected-psa-national-president 2016-06-24T16:00:01+10:00 https://pharmadispatch.com/news/stakeholders-meet-for-biosimilars-forum 2016-06-24T16:00:01+10:00 https://pharmadispatch.com/news/industry-coming-to-terms-with-brexit 2016-06-28T04:00:01+10:00 https://pharmadispatch.com/news/pbs-still-growing-but-is-all-as-it-seems 2016-06-27T16:00:01+10:00 https://pharmadispatch.com/news/ma-updates-on-organisational-change-and-leadership 2016-06-27T16:00:01+10:00 https://pharmadispatch.com/news/health-announcements-as-election-enters-final-week 2016-06-27T16:00:01+10:00 https://pharmadispatch.com/news/global-expert-says-biosimilars-promote-wider-use-of-cancer-thera 2016-06-28T16:00:01+10:00 https://pharmadispatch.com/news/pharmac-set-to-fund-pradaxa-antidote 2016-06-27T16:00:01+10:00 https://pharmadispatch.com/news/battle-for-medivation-heating-up 2016-06-27T16:00:01+10:00 https://pharmadispatch.com/news/does-anything-really-change-after-saturday 2016-06-28T16:00:01+10:00 https://pharmadispatch.com/news/looking-for-political-commitment-on-mrff 2016-06-28T16:00:01+10:00 https://pharmadispatch.com/news/chf-some-way-to-go-on-health-policy 2016-06-28T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-bi-agree-asset-swap 2016-06-28T16:00:01+10:00 https://pharmadispatch.com/news/mayne-acquires-us-generic-portfolio 2016-06-29T16:00:01+10:00 https://pharmadispatch.com/news/hcv-sales-top-one-billion 2016-06-29T16:00:01+10:00 https://pharmadispatch.com/news/shorten-scrapping-co-pay-hike-a-values-decision 2016-06-29T16:00:01+10:00 https://pharmadispatch.com/news/research-australia-calls-for-award-nominations 2016-06-29T00:34:01+10:00 https://pharmadispatch.com/news/pharmac-set-to-fund-keytruda 2016-06-29T16:00:01+10:00 https://pharmadispatch.com/news/could-listings-be-delayed-until-october 2016-06-30T16:00:01+10:00 https://pharmadispatch.com/news/few-surprises-in-election-responses-to-ma 2016-06-30T16:00:01+10:00 https://pharmadispatch.com/news/tga-extends-pilot-changes-to-pre-submission-process 2016-06-30T16:00:01+10:00 https://pharmadispatch.com/news/a-dramatic-but-illusory-growth-spurt 2016-06-30T16:00:01+10:00 https://pharmadispatch.com/news/labors-careful-wording-on-health 2016-07-01T16:00:01+10:00 https://pharmadispatch.com/news/next-week-for-price-cuts 2016-07-01T16:00:01+10:00 https://pharmadispatch.com/news/self-care-and-online-the-future-for-consumer-health 2016-07-01T16:00:01+10:00 https://pharmadispatch.com/news/msd-welcomes-tcs-prescribing-change 2016-07-01T16:00:01+10:00 https://pharmadispatch.com/news/mayne-shares-jump-after-us-deal 2016-07-01T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-donation-to-east-timor 2016-07-04T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-untenable-in-health 2016-07-04T16:00:01+10:00 https://pharmadispatch.com/news/election-good-for-some-not-so-for-others 2016-07-04T16:00:01+10:00 https://pharmadispatch.com/news/the-rise-of-xenophon-could-mark-the-end-of-king 2016-07-04T16:00:01+10:00 https://pharmadispatch.com/news/pbac-summary-documents-reveal-more 2016-07-04T16:00:01+10:00 https://pharmadispatch.com/news/new-analysis-backs-psa-program 2016-07-04T16:00:01+10:00 https://pharmadispatch.com/news/money-has-to-come-from-somewhere 2016-07-05T16:00:01+10:00 https://pharmadispatch.com/news/contemplating-a-labor-government 2016-07-05T16:00:01+10:00 https://pharmadispatch.com/news/priceline-gets-behind-female-athletes 2016-07-05T16:00:01+10:00 https://pharmadispatch.com/news/health-a-real-issue-for-us-admits-turnbull 2016-07-06T16:00:01+10:00 https://pharmadispatch.com/news/turnbulls-admission-the-first-step-of-many-in-health 2016-07-06T16:00:01+10:00 https://pharmadispatch.com/news/no-issue-with-new-ndss-arrangements 2016-07-06T16:00:01+10:00 https://pharmadispatch.com/news/abc-suspends-catalyst-reporter 2016-07-06T16:00:01+10:00 https://pharmadispatch.com/news/scott-morrison-may-have-missed-the-memo 2016-07-07T16:00:01+10:00 https://pharmadispatch.com/news/health-system-far-from-a-money-pit 2016-07-07T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-medivation-start-takeover-talks 2016-07-07T16:00:01+10:00 https://pharmadispatch.com/news/election-result-moves-closer 2016-07-07T16:00:01+10:00 https://pharmadispatch.com/news/gsk-vaccinates-australian-olympic-team 2016-07-08T16:00:01+10:00 https://pharmadispatch.com/news/ryan-dont-touch-medicare 2016-07-08T16:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-lodges-pbac-submission 2016-07-08T16:00:01+10:00 https://pharmadispatch.com/news/pharmac-adopts-new-decision-criteria 2016-07-08T16:00:01+10:00 https://pharmadispatch.com/news/dusc-documents-released 2016-07-11T16:00:01+10:00 https://pharmadispatch.com/news/gsk-and-az-join-brexit-taskforce 2016-07-11T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-not-interested-in-being-scapegoated 2016-07-11T16:00:01+10:00 https://pharmadispatch.com/news/true-impact-of-diabetes-epidemic-vastly-underestimated 2016-07-11T16:00:01+10:00 https://pharmadispatch.com/news/back-to-work-as-turnbull-claims-victory 2016-07-11T16:00:01+10:00 https://pharmadispatch.com/news/aids-no-longer-a-public-health-issue-say-experts 2016-07-10T16:00:01+10:00 https://pharmadispatch.com/news/pharmacy-service-the-future-for-pharmacy 2016-07-12T16:00:01+10:00 https://pharmadispatch.com/news/global-control-of-drug-pricing-an-undergraduate-concept 2016-07-11T22:55:01+10:00 https://pharmadispatch.com/news/genetic-test-could-reduce-need-for-chemo 2016-07-12T16:00:01+10:00 https://pharmadispatch.com/news/five-products-drive-growth-spike-in-retail-pharmacy 2016-07-12T16:00:01+10:00 https://pharmadispatch.com/news/coalition-will-need-to-find-a-new-reform-pathway 2016-07-13T16:00:01+10:00 https://pharmadispatch.com/news/new-senior-appointment-for-pharmacy-services-company 2016-07-14T04:00:01+10:00 https://pharmadispatch.com/news/finance-silent-on-pbs-review 2016-07-13T16:00:01+10:00 https://pharmadispatch.com/news/tolmar-backs-pioneering-prostate-cancer-research 2016-07-13T16:00:01+10:00 https://pharmadispatch.com/news/az-considering-bid-for-medivation 2016-07-13T16:00:01+10:00 https://pharmadispatch.com/news/no-briefings-to-ministers-officials-told 2016-07-14T16:00:01+10:00 https://pharmadispatch.com/news/more-information-means-improved-adherence 2016-07-14T16:00:01+10:00 https://pharmadispatch.com/news/department-announces-new-cmo 2016-07-14T16:00:01+10:00 https://pharmadispatch.com/news/arcs-extends-reach-with-new-global-partnership 2016-07-14T16:00:01+10:00 https://pharmadispatch.com/news/monday-is-d-day-for-pharmaceutical-sector 2016-07-15T16:00:01+10:00 https://pharmadispatch.com/news/court-victory-for-former-health-minister 2016-07-15T16:00:01+10:00 https://pharmadispatch.com/news/silence-on-health-but-not-hoverboards 2016-07-15T16:00:01+10:00 https://pharmadispatch.com/news/psa-starts-review-of-key-documents 2016-07-15T16:00:01+10:00 https://pharmadispatch.com/news/the-hidden-impact-of-osteoporosis 2016-07-15T16:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-ceo-hands-over-leadership 2016-07-15T16:49:01+10:00 https://pharmadispatch.com/news/we-need-to-have-the-confidence-to-engage 2016-07-18T16:00:01+10:00 https://pharmadispatch.com/news/osteoporosis-therapy-delisted-from-1-august 2016-07-18T16:00:01+10:00 https://pharmadispatch.com/news/australia-wants-to-steal-us-patents 2016-07-18T16:00:01+10:00 https://pharmadispatch.com/news/is-the-managed-entry-scheme-dead 2016-07-18T16:00:01+10:00 https://pharmadispatch.com/news/ma-pays-tribute-to-outgoing-ausbiotech-ceo 2016-07-18T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-retains-health 2016-07-18T17:00:01+10:00 https://pharmadispatch.com/news/under-co-pay-data-confirms-transformation 2016-07-19T16:00:01+10:00 https://pharmadispatch.com/news/get-ready-for-1-october 2016-07-19T16:00:01+10:00 https://pharmadispatch.com/news/not-much-has-changed 2016-07-19T16:00:01+10:00 https://pharmadispatch.com/news/sigma-adds-new-senior-strategy-role-to-executive 2016-07-19T15:38:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-new-ministry 2016-07-19T16:00:01+10:00 https://pharmadispatch.com/news/august-pbs-for-biosimilar-ivf-therapy 2016-07-21T16:00:01+10:00 https://pharmadispatch.com/news/changes-for-labor-frontbench 2016-07-20T16:00:01+10:00 https://pharmadispatch.com/news/wholesalers-looking-forward-to-review-discussion-paper 2016-07-20T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-merck-australia 2016-07-20T16:00:01+10:00 https://pharmadispatch.com/news/post-election-departures-from-sussan-leys-office 2016-07-20T16:01:01+10:00 https://pharmadispatch.com/news/pfizer-kicks-off-anniversary-celebrations 2016-07-21T16:00:01+10:00 https://pharmadispatch.com/news/jj-raises-full-year-forecast 2016-07-21T16:00:01+10:00 https://pharmadispatch.com/news/new-guidelines-will-impact-innovation 2016-07-21T16:00:01+10:00 https://pharmadispatch.com/news/price-disclosure-change-not-all-that-it-seems 2016-07-21T16:00:01+10:00 https://pharmadispatch.com/news/back-to-work-for-sussan-ley 2016-07-22T16:00:01+10:00 https://pharmadispatch.com/news/hcv-sales-close-in-on-11bn 2016-07-22T16:00:01+10:00 https://pharmadispatch.com/news/roche-still-resisting-infliximab-comparator 2016-07-22T16:00:01+10:00 https://pharmadispatch.com/news/strong-first-half-result-for-roche 2016-07-22T16:00:01+10:00 https://pharmadispatch.com/news/who-thought-that-would-be-a-good-idea 2016-07-22T16:20:01+10:00 https://pharmadispatch.com/news/new-chief-of-staff-for-sussan-ley 2016-07-25T16:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-labor-ministry 2016-07-25T16:00:01+10:00 https://pharmadispatch.com/news/tightly-held-process-coming-to-an-end 2016-07-25T16:00:01+10:00 https://pharmadispatch.com/news/tga-approves-first-biosimilar-etanercept 2016-07-25T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-on-the-attack 2016-07-25T16:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-policy-stability-essential 2016-07-26T16:00:01+10:00 https://pharmadispatch.com/news/official-pbs-data-catching-up 2016-07-26T16:00:01+10:00 https://pharmadispatch.com/news/full-year-data-reveals-spike-but-is-it-real 2016-07-26T16:00:01+10:00 https://pharmadispatch.com/news/hunt-the-changing-face-of-australian-innovation 2016-07-26T16:00:01+10:00 https://pharmadispatch.com/news/the-pbs-as-a-safety-net-1 2016-07-27T16:00:01+10:00 https://pharmadispatch.com/news/garvan-to-launch-first-clinical-whole-genome-sequencing-service 2016-07-27T16:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-biosimilar-etanercept 2016-07-27T16:00:01+10:00 https://pharmadispatch.com/news/pharmacy-discussion-paper-contentious-and-provocative 2016-07-27T16:00:01+10:00 https://pharmadispatch.com/news/stakeholders-cautiously-welcome-review-discussion-paper 2016-07-28T16:00:01+10:00 https://pharmadispatch.com/news/at-least-one-question-already-answered 2016-07-28T16:00:01+10:00 https://pharmadispatch.com/news/tambassis-review-forgot-one-question 2016-07-28T16:00:01+10:00 https://pharmadispatch.com/news/australia-leading-the-world 2016-07-28T16:00:01+10:00 https://pharmadispatch.com/news/gsk-posts-strong-results-and-invests-in-uk 2016-07-28T16:00:01+10:00 https://pharmadispatch.com/news/az-inks-new-deal-with-australian-biotech 2016-07-29T16:00:01+10:00 https://pharmadispatch.com/news/csl-welcomes-qiv-approval 2016-07-29T16:00:01+10:00 https://pharmadispatch.com/news/amgen-raises-outlook-on-sales-growth 2016-07-29T16:00:01+10:00 https://pharmadispatch.com/news/gsk-partners-with-nps-commercial-arm 2016-07-29T16:00:01+10:00 https://pharmadispatch.com/news/minister-celebrates-early-hcv-success 2016-07-29T16:00:01+10:00 https://pharmadispatch.com/news/more-change-in-sussan-leys-office 2016-07-29T16:01:01+10:00 https://pharmadispatch.com/news/richard-vines-equity-should-be-a-reason-to-fund-access-not-an-ex 2016-08-01T16:00:01+10:00 https://pharmadispatch.com/news/minor-breaches-cost-bms-10000 2016-08-01T16:00:01+10:00 https://pharmadispatch.com/news/stakeholders-report-changed-approach 2016-08-01T16:00:01+10:00 https://pharmadispatch.com/news/launches-boost-msd 2016-08-01T16:00:01+10:00 https://pharmadispatch.com/news/sanofi-ready-to-progress-medivation-takeover 2016-08-01T16:00:01+10:00 https://pharmadispatch.com/news/consultation-process-underway-today 2016-08-01T16:00:01+10:00 https://pharmadispatch.com/news/tariff-hit-for-clinical-trials 2016-08-02T16:00:01+10:00 https://pharmadispatch.com/news/comparators-still-troubling-industry 2016-08-02T16:00:01+10:00 https://pharmadispatch.com/news/it-actually-shows-the-complete-opposite-of-that 2016-08-02T16:00:01+10:00 https://pharmadispatch.com/news/no-jab-no-pay-working 2016-08-02T16:00:01+10:00 https://pharmadispatch.com/news/new-cuts-for-combination-items 2016-08-02T16:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-awards-open-for-applications 2016-08-03T16:00:01+10:00 https://pharmadispatch.com/news/pharmac-confirms-keytruda-funding 2016-08-03T16:00:01+10:00 https://pharmadispatch.com/news/pbac-facing-a-year-of-change 2016-08-04T16:00:01+10:00 https://pharmadispatch.com/news/legacy-hospira-and-new-products-boost-pfizer 2016-08-03T16:00:01+10:00 https://pharmadispatch.com/news/biogen-attracts-interest 2016-08-03T16:00:01+10:00 https://pharmadispatch.com/news/industry-looks-to-rally-on-comparators 2016-08-03T16:00:01+10:00 https://pharmadispatch.com/news/gender-a-consideration-for-pbac 2016-08-04T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-appointed-to-erc 2016-08-05T16:00:01+10:00 https://pharmadispatch.com/news/minister-announces-details-of-btf 2016-08-04T16:00:01+10:00 https://pharmadispatch.com/news/fundamental-misunderstanding-on-clinical-trials 2016-08-04T16:00:01+10:00 https://pharmadispatch.com/news/merger-creates-pharmacy-giant 2016-08-05T16:00:01+10:00 https://pharmadispatch.com/news/ma-loses-another-member 2016-08-05T16:00:01+10:00 https://pharmadispatch.com/news/still-sorting-ministerial-responsibilities 2016-08-05T16:00:01+10:00 https://pharmadispatch.com/news/guidelines-done-by-november-but-industry-not-giving-up 2016-08-08T16:00:01+10:00 https://pharmadispatch.com/news/industry-concern-over-tga-committee-changes 2016-08-08T16:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-supports-cv-research-innovation 2016-08-08T16:00:01+10:00 https://pharmadispatch.com/news/evidence-backs-ezetimibe-price-increase 2016-08-08T16:00:01+10:00 https://pharmadispatch.com/news/disappointment-as-key-immunotherapy-misses-study-endpoint 2016-08-08T16:00:01+10:00 https://pharmadispatch.com/news/new-partnership-for-capital-k 2016-08-09T16:00:01+10:00 https://pharmadispatch.com/news/recognition-for-pharmacy-chain 2016-08-09T16:00:01+10:00 https://pharmadispatch.com/news/jj-backs-health-innovation-competition 2016-08-09T16:00:01+10:00 https://pharmadispatch.com/news/companies-question-private-meeting 2016-08-09T16:00:01+10:00 https://pharmadispatch.com/news/pharmac-funds-pradaxa-antidote 2016-08-09T16:00:01+10:00 https://pharmadispatch.com/news/is-regulator-shifting-on-product-information 2016-08-10T16:00:01+10:00 https://pharmadispatch.com/news/patients-not-effectively-managing-diabetes 2016-08-10T16:00:01+10:00 https://pharmadispatch.com/news/comparator-change-a-tipping-point-for-access 2016-08-10T16:00:01+10:00 https://pharmadispatch.com/news/another-program-to-support-collaborations 2016-08-10T16:00:01+10:00 https://pharmadispatch.com/news/biogen-unveils-new-name-for-haemophilia-spin-off 2016-08-10T16:00:01+10:00 https://pharmadispatch.com/news/cmi-push-impractical-and-dangerous 2016-08-11T16:00:01+10:00 https://pharmadispatch.com/news/reform-in-need-of-a-long-term-vision 2016-08-11T16:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-consumer-support-for-pharmacy 2016-08-11T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-pharmacy-trials-must-be-rolled-out-quickly 2016-08-11T16:00:01+10:00 https://pharmadispatch.com/news/four-year-transition-for-label-changes 2016-08-11T16:00:01+10:00 https://pharmadispatch.com/news/dusc-confirms-review-targets 2016-08-11T16:00:01+10:00 https://pharmadispatch.com/news/immigration-wants-further-discussions-on-clinical-trials-tax 2016-08-12T16:00:01+10:00 https://pharmadispatch.com/news/blackmores-to-launch-online-medicine-interaction-tool 2016-08-12T16:00:01+10:00 https://pharmadispatch.com/news/drive-change-rather-than-respond-to-it 2016-08-12T16:00:01+10:00 https://pharmadispatch.com/news/choosing-wisely-targets-medicine-use-by-older-australians 2016-08-12T16:00:01+10:00 https://pharmadispatch.com/news/make-or-break-meeting-on-comparators 2016-08-15T16:00:01+10:00 https://pharmadispatch.com/news/we-need-more-diversity-in-our-leadership-says-abbvies-kirsten-od 2016-08-15T16:00:01+10:00 https://pharmadispatch.com/news/minister-gets-in-front-on-new-listings 2016-08-15T16:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-questions-tpp-response 2016-08-15T16:00:01+10:00 https://pharmadispatch.com/news/easier-ways-to-delay-listings-than-deferrals 2016-08-15T16:00:01+10:00 https://pharmadispatch.com/news/the-battle-has-only-just-begun 2016-08-16T16:00:01+10:00 https://pharmadispatch.com/news/sussan-ley-recruits-another-senior-staffer 2016-08-16T16:00:01+10:00 https://pharmadispatch.com/news/biogen-backs-student-biotech-showcase 2016-08-16T16:00:01+10:00 https://pharmadispatch.com/news/potential-resolution-on-comparators 2016-08-16T16:00:01+10:00 https://pharmadispatch.com/news/compound-derived-from-australian-rainforest-progresses-in-human 2016-08-16T16:00:01+10:00 https://pharmadispatch.com/news/ministers-office-takes-shape 2016-08-17T16:00:01+10:00 https://pharmadispatch.com/news/looking-for-review-outcomes 2016-08-17T16:00:01+10:00 https://pharmadispatch.com/news/chf-data-release-a-treasure-trove 2016-08-17T16:00:01+10:00 https://pharmadispatch.com/news/ma-updates-members-on-comparator-wording 2016-08-17T16:01:01+10:00 https://pharmadispatch.com/news/csl-expecting-strong-growth-ahead 2016-08-18T16:00:01+10:00 https://pharmadispatch.com/news/viiv-grants-for-hiv-care 2016-08-25T16:00:01+10:00 https://pharmadispatch.com/news/no-pbs-in-savings-bill 2016-08-18T16:00:01+10:00 https://pharmadispatch.com/news/novartis-set-to-award-major-prizes-in-melbourne 2016-08-18T16:00:01+10:00 https://pharmadispatch.com/news/asmi-welcomes-labelling-order 2016-08-18T16:00:01+10:00 https://pharmadispatch.com/news/msd-joins-race-for-medivation 2016-08-18T16:00:01+10:00 https://pharmadispatch.com/news/bayer-not-giving-up-on-monsanto 2016-08-20T04:00:01+10:00 https://pharmadispatch.com/news/innovative-abbvie-recognised-for-the-fifth-year-in-a-row 2016-08-19T16:00:01+10:00 https://pharmadispatch.com/news/nz-patients-suffering-and-dying 2016-08-19T16:00:01+10:00 https://pharmadispatch.com/news/outcry-in-uk-over-nice-decision-on-cancer-therapies 2016-08-19T16:00:01+10:00 https://pharmadispatch.com/news/time-to-move-this-debate-on 2016-08-21T20:28:01+10:00 https://pharmadispatch.com/news/greens-want-wonder-drug-work-around-after-pbac-rejection 2016-08-22T16:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-time-to-take-charge 2016-08-22T16:00:01+10:00 https://pharmadispatch.com/news/pbac-has-another-go-at-managed-entry 2016-08-22T16:00:01+10:00 https://pharmadispatch.com/news/july-pbac-outcomes 2016-08-22T16:00:01+10:00 https://pharmadispatch.com/news/educational-changes-going-well-in-australia-says-gsk-leader 2016-08-23T01:24:01+10:00 https://pharmadispatch.com/news/press-gallery-and-political-veteran-joins-ley-staff 2016-08-23T16:00:01+10:00 https://pharmadispatch.com/news/age-matters-when-it-comes-to-medicine-use 2016-08-23T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-wins-battle-for-medivation 2016-08-23T16:00:01+10:00 https://pharmadispatch.com/news/lichtenberg-a-positive-but-slow-impact-from-new-cancer-drugs 2016-08-24T16:00:01+10:00 https://pharmadispatch.com/news/first-study-shows-impact-of-new-medicines-in-nz 2016-08-24T16:00:01+10:00 https://pharmadispatch.com/news/bayer-and-monsanto-edging-towards-deal 2016-08-24T16:00:01+10:00 https://pharmadispatch.com/news/time-for-hay-fever-help-1 2016-08-24T16:00:01+10:00 https://pharmadispatch.com/news/industry-critic-questions-abc-deal-with-swisse-1 2016-08-24T16:00:01+10:00 https://pharmadispatch.com/news/new-ceo-for-medicines-australia 2016-08-24T17:29:01+10:00 https://pharmadispatch.com/news/new-leadership-but-the-challenge-remains-the-same 2016-08-25T16:00:01+10:00 https://pharmadispatch.com/news/gsk-tops-change-the-world-list 2016-08-25T16:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-another-biosimilar-infliximab 2016-08-25T16:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-health-care-homes-but-not-at-the-expense-of-pharm 2016-08-25T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-adds-az-antibiotics-business 2016-08-25T15:00:01+10:00 https://pharmadispatch.com/news/busy-november-meeting-for-pbac 2016-08-25T16:00:01+10:00 https://pharmadispatch.com/news/hcv-boosts-ebos-result 2016-08-26T16:00:01+10:00 https://pharmadispatch.com/news/upward-trend-continues 2016-08-26T16:00:01+10:00 https://pharmadispatch.com/news/michael-wonder-breaks-down-november-pbac-agenda 2016-08-26T16:00:01+10:00 https://pharmadispatch.com/news/milton-catelin-the-standout-candidate 2016-08-26T16:00:01+10:00 https://pharmadispatch.com/news/di-natale-keeps-health-in-reshuffle 2016-08-26T16:00:01+10:00 https://pharmadispatch.com/news/more-money-for-mrff 2016-08-29T16:00:01+10:00 https://pharmadispatch.com/news/review-questionnaire-raising-questions 2016-08-29T16:00:01+10:00 https://pharmadispatch.com/news/record-growth-for-the-new-mayne 2016-08-29T16:00:01+10:00 https://pharmadispatch.com/news/industry-in-trouble-over-pricing-again 2016-08-29T00:31:01+10:00 https://pharmadispatch.com/news/the-needle-matters-for-diabetics 2016-08-29T16:00:01+10:00 https://pharmadispatch.com/news/test-for-new-comparator-wording 2016-08-29T16:00:01+10:00 https://pharmadispatch.com/news/brilliant-innovation-policy-but-mixed-messages-a-risk 2016-08-30T16:00:01+10:00 https://pharmadispatch.com/news/linfox-moves-into-supply-chain 2016-08-30T16:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-appoints-leadership-group 2016-08-30T16:00:01+10:00 https://pharmadispatch.com/news/office-move-for-csl-behring 2016-08-30T16:00:01+10:00 https://pharmadispatch.com/news/international-award-for-health-destination-program 2016-08-30T16:00:01+10:00 https://pharmadispatch.com/news/tga-warns-on-overseas-weight-loss-drugs 2016-08-31T16:00:01+10:00 https://pharmadispatch.com/news/guild-backs-call-for-action-on-real-time-monitoring 2016-08-31T16:00:01+10:00 https://pharmadispatch.com/news/who-really-owns-the-ramsay-pharmacies 2016-08-31T16:00:01+10:00 https://pharmadispatch.com/news/biosimilars-coming-together-for-innovative-health-policy 2016-08-31T16:00:01+10:00 https://pharmadispatch.com/news/historic-day-for-industry 2016-08-31T16:00:01+10:00 https://pharmadispatch.com/news/abbvie-makesbest-employer-list 2016-08-31T02:49:01+10:00 https://pharmadispatch.com/news/government-acts-on-national-cancer-registry 2016-08-31T16:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-ongoing-price-hit-to-pharmacy 2016-09-01T16:00:01+10:00 https://pharmadispatch.com/news/only-demonstrates-the-need-to-question-the-process 2016-09-01T16:00:01+10:00 https://pharmadispatch.com/news/reports-largely-as-expected 2016-09-01T15:00:01+10:00 https://pharmadispatch.com/news/coalition-moves-on-rd-tax-cut 2016-09-01T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-takes-charge-of-ausbiotech 2016-09-02T16:00:01+10:00 https://pharmadispatch.com/news/rd-tax-cut-pushed-back-a-year 2016-09-02T16:00:01+10:00 https://pharmadispatch.com/news/guidelines-progressing-toward-sign-off 2016-09-02T16:00:01+10:00 https://pharmadispatch.com/news/chf-wants-more-on-transparency 2016-09-02T16:00:01+10:00 https://pharmadispatch.com/news/new-global-leadership-for-novo-nordisk 2016-09-02T16:00:01+10:00 https://pharmadispatch.com/news/forum-report-calls-for-more-action 2016-09-05T16:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-criticises-lack-of-consultation-on-rd-cut 2016-09-04T20:56:01+10:00 https://pharmadispatch.com/news/official-announcement-imminent 2016-09-05T16:00:01+10:00 https://pharmadispatch.com/news/minster-takes-charge-of-tga 2016-09-05T16:00:01+10:00 https://pharmadispatch.com/news/australia-could-miss-out-on-biosimilar-opportunity 2016-09-05T16:00:01+10:00 https://pharmadispatch.com/news/minister-marks-2bn-price-cuts 2016-09-05T16:00:01+10:00 https://pharmadispatch.com/news/australians-back-mrff-investment 2016-09-06T16:00:01+10:00 https://pharmadispatch.com/news/pbs-changes-have-led-to-under-treatment 2016-09-06T16:00:01+10:00 https://pharmadispatch.com/news/gsk-updates-on-positive-copd-study 2016-09-06T16:00:01+10:00 https://pharmadispatch.com/news/msd-readies-for-zepatier-launch 2016-09-06T16:00:01+10:00 https://pharmadispatch.com/news/dorothy-not-going-it-alone-in-pfizers-latest-social-media-campai 2016-09-07T16:00:01+10:00 https://pharmadispatch.com/news/pharmacy-backs-mbs-opportunity 2016-09-07T16:00:01+10:00 https://pharmadispatch.com/news/bayer-ups-offer-for-monsanto 2016-09-07T16:00:01+10:00 https://pharmadispatch.com/news/mark-crotty-the-new-ceo-of-juno 2016-09-07T16:00:01+10:00 https://pharmadispatch.com/news/guild-staffer-joins-ministers-office 2016-09-08T16:00:01+10:00 https://pharmadispatch.com/news/mining-health-data-the-future-not-mining 2016-09-08T16:00:01+10:00 https://pharmadispatch.com/news/first-generic-glivec-for-1-october 2016-09-08T16:00:01+10:00 https://pharmadispatch.com/news/landmark-listing-that-framed-access-debate 2016-09-08T16:00:01+10:00 https://pharmadispatch.com/news/wes-cook-reappointed-ma-chair 2016-09-09T16:00:01+10:00 https://pharmadispatch.com/news/second-brand-dispute-may-never-be-resolved 2016-09-09T16:00:01+10:00 https://pharmadispatch.com/news/hep-c-and-retail-boosts-sigma-result 2016-09-09T16:00:01+10:00 https://pharmadispatch.com/news/pbac-veteran-to-lead-government-prostheses-group 2016-09-09T16:00:01+10:00 https://pharmadispatch.com/news/i-learnt-how-to-spell-pharmacoeconomics 2016-09-12T16:00:01+10:00 https://pharmadispatch.com/news/try-again-on-pbac-nomination 2016-09-12T16:00:01+10:00 https://pharmadispatch.com/news/australians-with-psoriasis-feel-discrimination-and-bullying 2016-09-11T21:01:01+10:00 https://pharmadispatch.com/news/statins-better-than-thought 2016-09-12T16:00:01+10:00 https://pharmadispatch.com/news/consumers-benefit-from-pharmacy-regulation 2016-09-12T16:00:01+10:00 https://pharmadispatch.com/news/ma-moves-organisation-to-long-term-focus 2016-09-12T16:00:01+10:00 https://pharmadispatch.com/news/new-pbac-member-appointed-to-run-mental-health-commission 2016-09-13T16:00:01+10:00 https://pharmadispatch.com/news/official-extends-time-at-tga 2016-09-13T16:00:01+10:00 https://pharmadispatch.com/news/accc-secures-undertaking-on-genetic-test 2016-09-13T16:00:01+10:00 https://pharmadispatch.com/news/movements-in-anti-hypertensive-market 2016-09-13T16:00:01+10:00 https://pharmadispatch.com/news/ley-system-will-cannibalise-itself-without-reform 2016-09-13T16:00:01+10:00 https://pharmadispatch.com/news/australian-secures-award-grant-from-merck 2016-09-13T16:00:01+10:00 https://pharmadispatch.com/news/labor-backs-rd-tax-cut-bill 2016-09-14T16:00:01+10:00 https://pharmadispatch.com/news/does-tppa-actually-mean-any-change 2016-09-14T16:00:01+10:00 https://pharmadispatch.com/news/australians-consider-themselves-healthy-but 2016-09-14T16:00:01+10:00 https://pharmadispatch.com/news/pbs-brake-on-government-health-spending 2016-09-14T16:00:01+10:00 https://pharmadispatch.com/news/minister-slams-labor-over-cancer-registry 2016-09-14T16:00:01+10:00 https://pharmadispatch.com/news/bayer-raises-offer-for-monsanto 2016-09-14T16:00:01+10:00 https://pharmadispatch.com/news/pbs-a-risk-to-budget-repair 2016-09-15T16:00:01+10:00 https://pharmadispatch.com/news/australia-worst-in-world-for-financial-stress-in-lymphoma-fight 2016-09-15T16:00:01+10:00 https://pharmadispatch.com/news/promotion-for-labor-senator 2016-09-15T16:00:01+10:00 https://pharmadispatch.com/news/minister-ley-reforms-mean-faster-access 2016-09-15T16:00:01+10:00 https://pharmadispatch.com/news/tga-review-government-responses-to-the-key-recommendations 2016-09-15T16:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-government-response-to-tga-review 2016-09-15T16:00:01+10:00 https://pharmadispatch.com/news/government-congratulated-for-tga-review-response 2016-09-16T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-gsk-australia 2016-09-16T00:59:01+10:00 https://pharmadispatch.com/news/regulation-reform-welcome-but-get-reimbursement-right 2016-09-16T16:00:01+10:00 https://pharmadispatch.com/news/industry-you-deserve-much-better-than-this 2016-09-16T16:00:01+10:00 https://pharmadispatch.com/news/the-senate-has-its-response 2016-09-16T16:00:01+10:00 https://pharmadispatch.com/news/jane-halton-resigns-from-finance 2016-09-16T20:48:01+10:00 https://pharmadispatch.com/news/familiar-face-for-finance 2016-09-19T16:04:01+10:00 https://pharmadispatch.com/news/senate-passes-rd-tax-cut 2016-09-19T16:00:01+10:00 https://pharmadispatch.com/news/ley-human-consequences-always-outweigh-the-financial-consequence 2016-09-19T16:03:01+10:00 https://pharmadispatch.com/news/patients-before-profits 2016-09-19T16:00:01+10:00 https://pharmadispatch.com/news/jj-adds-to-medical-optics-business 2016-09-19T16:00:01+10:00 https://pharmadispatch.com/news/hacking-their-way-to-healthcare-solutions 2016-09-19T16:00:01+10:00 https://pharmadispatch.com/news/halton-leaves-a-remarkable-pbs-legacy 2016-09-19T16:05:01+10:00 https://pharmadispatch.com/news/patents-are-not-the-issue-when-it-comes-to-access 2016-09-28T04:00:01+10:00 https://pharmadispatch.com/news/expanded-tga-approval-for-kalydeco 2016-09-20T16:00:01+10:00 https://pharmadispatch.com/news/mtaa-chief-executive-resigns 2016-09-20T16:03:01+10:00 https://pharmadispatch.com/news/former-victorian-premier-to-lead-cancer-drugs-access-push 2016-09-20T16:05:01+10:00 https://pharmadispatch.com/news/gsk-backed-open-source-malaria-study 2016-09-20T16:00:01+10:00 https://pharmadispatch.com/news/amgen-and-ucb-announce-positive-results-of-osteoporosis-study-1 2016-09-20T16:00:01+10:00 https://pharmadispatch.com/news/from-country-victoria-to-leading-pfizer-australia 2016-09-21T16:00:01+10:00 https://pharmadispatch.com/news/industry-biosimilar-group-set-to-continue 2016-09-21T16:00:01+10:00 https://pharmadispatch.com/news/gsk-confirms-witty-successor 2016-09-21T16:00:01+10:00 https://pharmadispatch.com/news/bayer-promotes-improved-outlook 2016-09-21T16:00:01+10:00 https://pharmadispatch.com/news/greens-go-hard-against-tpp 2016-09-21T16:00:01+10:00 https://pharmadispatch.com/news/acquisition-boosts-terry-white-result 2016-09-22T16:00:01+10:00 https://pharmadispatch.com/news/bayer-could-drop-monsanto-name 2016-09-22T16:30:01+10:00 https://pharmadispatch.com/news/all-may-not-be-as-it-seems-but-who-will-know 2016-09-22T16:00:01+10:00 https://pharmadispatch.com/news/more-work-needed-on-antimicrobial-resistance 2016-09-22T16:00:01+10:00 https://pharmadispatch.com/news/valeant-moves-to-sell-inova 2016-09-23T16:00:01+10:00 https://pharmadispatch.com/news/uwa-drug-offers-new-hope-to-young-muscular-dystrophy-sufferers 2016-09-23T16:00:01+10:00 https://pharmadispatch.com/news/king-calls-for-submissions 2016-09-23T16:00:01+10:00 https://pharmadispatch.com/news/the-mystery-that-is-finance 2016-09-23T16:01:01+10:00 https://pharmadispatch.com/news/fda-approves-amgens-humira-biosimilar 2016-09-26T16:00:01+10:00 https://pharmadispatch.com/news/warning-signs-pbs-not-stopping 2016-09-26T16:00:01+10:00 https://pharmadispatch.com/news/independent-reviews-downgraded-1 2016-09-26T16:03:01+10:00 https://pharmadispatch.com/news/of-course-its-about-influencing-prescribing-thats-the-point 2016-09-26T16:04:01+10:00 https://pharmadispatch.com/news/online-too-to-calculate-pbs-savings 2016-09-26T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-decides-against-split 2016-09-27T16:00:01+10:00 https://pharmadispatch.com/news/policy-addressing-regulation-bottlenecks 2016-09-27T16:00:01+10:00 https://pharmadispatch.com/news/un-gets-it-wrong-on-access-barriers 2016-09-27T16:00:01+10:00 https://pharmadispatch.com/news/dont-ignore-backdown-on-backpacker-tax 2016-09-28T16:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-secures-another-bronchitol-approval 2016-09-28T16:00:01+10:00 https://pharmadispatch.com/news/pricing-only-has-to-be-reasonably-viable 2016-09-28T16:00:01+10:00 https://pharmadispatch.com/news/first-line-study-outcome-for-amgens-multiple-myeloma-therapy 2016-09-28T16:00:01+10:00 https://pharmadispatch.com/news/review-calls-for-reform-of-rd-tax-incentive 2016-09-29T16:00:01+10:00 https://pharmadispatch.com/news/business-welcomes-rd-tax-report-but-cautions-on-change 2016-09-29T16:00:01+10:00 https://pharmadispatch.com/news/tga-approval-times-dropped-in-2015-16 2016-09-29T09:05:01+10:00 https://pharmadispatch.com/news/recognition-for-psa-pharmacist 2016-09-29T16:00:01+10:00 https://pharmadispatch.com/news/mylan-and-lupin-consider-bids-for-bayer-dermatology 2016-09-29T16:00:01+10:00 https://pharmadispatch.com/news/dont-try-aggressive-approaches-with-me 2016-09-29T16:00:01+10:00 https://pharmadispatch.com/news/cso-is-essential-and-not-lazy-policy 2016-09-30T16:00:01+10:00 https://pharmadispatch.com/news/cutting-to-the-quick 2016-09-30T16:00:01+10:00 https://pharmadispatch.com/news/trouble-over-data-overblown 2016-09-30T16:00:01+10:00 https://pharmadispatch.com/news/department-invites-applicants-to-access-cso-and-ndss 2016-09-30T16:00:01+10:00 https://pharmadispatch.com/news/bayer-welcomes-advertising-sanction-2 2016-09-30T16:00:01+10:00 https://pharmadispatch.com/news/when-power-fails-wholesalers-surge-2 2016-09-30T10:20:01+10:00 https://pharmadispatch.com/news/budget-outcome-confirms-pbs-spike 2016-09-30T23:24:01+10:00 https://pharmadispatch.com/news/ministerial-praise-for-astrazeneca 2016-10-04T17:00:01+11:00 https://pharmadispatch.com/news/minister-wants-to-hear-from-industry 2016-10-04T17:00:01+11:00 https://pharmadispatch.com/news/issues-in-illusory-growth 2016-10-04T17:00:01+11:00 https://pharmadispatch.com/news/pbac-recommends-novartis-heart-failure-therapy 2016-10-04T17:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-csl-behrings-long-acting-haemophilia-treatment 2016-10-04T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-completes-hospira-integration 2016-10-04T17:00:01+11:00 https://pharmadispatch.com/news/az-licences-biologic-to-allergan 2016-10-04T17:00:01+11:00 https://pharmadispatch.com/news/new-appointments-in-pharmaceutical-evaluation 2016-10-05T17:00:01+11:00 https://pharmadispatch.com/news/sussan-ley-takes-tga 2016-10-05T17:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-amgen-australia 2016-10-05T17:00:01+11:00 https://pharmadispatch.com/news/wider-pbs-access-for-novartis-interleukin-17a-inhibitor 2016-10-05T17:00:01+11:00 https://pharmadispatch.com/news/funding-boost-for-australian-healthcare-startups 2016-10-05T17:00:01+11:00 https://pharmadispatch.com/news/deregulation-or-regulation 2016-10-06T17:00:01+11:00 https://pharmadispatch.com/news/an-opportunity-to-celebrate-australian-researchers 2016-10-06T17:00:01+11:00 https://pharmadispatch.com/news/pbac-vacancies-as-industry-goes-again 2016-10-06T17:01:01+11:00 https://pharmadispatch.com/news/discovery-could-accelerate-drug-development 2016-10-06T17:00:01+11:00 https://pharmadispatch.com/news/bill-ferris-we-have-to-get-better-at-collaboration 2016-10-06T17:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-api 2016-10-07T17:00:01+11:00 https://pharmadispatch.com/news/australians-prioritise-health-and-medical-research 2016-10-07T17:00:01+11:00 https://pharmadispatch.com/news/consumers-making-their-own-choices 2016-10-07T17:00:01+11:00 https://pharmadispatch.com/news/labor-moves-to-block-telstra-health 2016-10-07T17:00:01+11:00 https://pharmadispatch.com/news/a-major-shift-for-pbs-eye-therapies 2016-10-10T17:00:01+11:00 https://pharmadispatch.com/news/1-november-pbs-listings-and-lowest-cost-comparator 2016-10-10T17:00:01+11:00 https://pharmadispatch.com/news/richard-vines-the-moral-discussion-is-over 2016-10-10T17:00:01+11:00 https://pharmadispatch.com/news/no-room-for-complacency-on-mental-health 2016-10-10T17:00:01+11:00 https://pharmadispatch.com/news/jj-acquires-rights-to-azs-rhinocort 2016-10-10T17:00:01+11:00 https://pharmadispatch.com/news/psa-rebukes-hospital-pharmacists 2016-10-10T17:00:01+11:00 https://pharmadispatch.com/news/cancer-therapies-grabbing-headlines 2016-10-11T17:00:01+11:00 https://pharmadispatch.com/news/gsk-in-the-clear-on-panadol-osteo 2016-10-11T17:00:01+11:00 https://pharmadispatch.com/news/brian-gladsden-industrys-call-to-action 2016-10-11T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-sticking-with-originators 2016-10-11T05:20:01+11:00 https://pharmadispatch.com/news/ex-sanofi-boss-new-head-of-consumer-brand-company 2016-10-11T08:37:01+11:00 https://pharmadispatch.com/news/predatory-pricing-and-1-december-increases 2016-10-12T17:00:01+11:00 https://pharmadispatch.com/news/tga-updates-advisory-statement-for-nsaids 2016-10-12T17:00:01+11:00 https://pharmadispatch.com/news/get-out-from-behind-the-shadows 2016-10-12T17:00:01+11:00 https://pharmadispatch.com/news/pm-uses-pbs-in-health-attack 2016-10-12T17:00:01+11:00 https://pharmadispatch.com/news/government-considering-new-innovation-fund 2016-10-12T17:00:01+11:00 https://pharmadispatch.com/news/value-means-different-things-to-different-people 2016-10-13T17:00:01+11:00 https://pharmadispatch.com/news/savings-getting-harder-to-find 2016-10-13T17:00:01+11:00 https://pharmadispatch.com/news/first-speech-for-pharmacist-mp 2016-10-13T17:00:01+11:00 https://pharmadispatch.com/news/guidelines-confirm-positive-outcome-on-comparators 2016-10-13T17:00:01+11:00 https://pharmadispatch.com/news/new-therapy-for-specialised-therapeutics-1 2016-10-13T17:00:01+11:00 https://pharmadispatch.com/news/pm-turns-to-pbs-again 2016-10-14T17:00:01+11:00 https://pharmadispatch.com/news/senate-backs-new-national-cancer-register 2016-10-14T17:00:01+11:00 https://pharmadispatch.com/news/recognition-for-australian-prostate-cancer-innovation 2016-10-14T17:00:01+11:00 https://pharmadispatch.com/news/funding-confirmed-for-shingles-vaccine 2016-10-14T17:00:01+11:00 https://pharmadispatch.com/news/stakeholders-meet-for-rare-cancers 2016-10-17T17:05:01+11:00 https://pharmadispatch.com/news/pbs-process-could-change-in-response-to-tga-review 2016-10-17T17:06:01+11:00 https://pharmadispatch.com/news/cholesterol-lowering-drug-headlines-price-disclosure-additions 2016-10-17T17:03:01+11:00 https://pharmadispatch.com/news/global-access-to-radiation-therapy-could-save-four-million-lives 2016-10-17T17:00:01+11:00 https://pharmadispatch.com/news/tga-proposes-changes-to-orphan-drug-program 2016-10-17T17:04:01+11:00 https://pharmadispatch.com/news/another-round-of-senate-estimates 2016-10-17T17:00:01+11:00 https://pharmadispatch.com/news/merck-delivers-update-strategic-plan 2016-10-17T17:01:01+11:00 https://pharmadispatch.com/news/can-prices-fall-any-further 2016-10-18T17:02:01+11:00 https://pharmadispatch.com/news/new-research-centre-in-queensland 2016-10-18T17:01:01+11:00 https://pharmadispatch.com/news/rebates-top-15-billion 2016-10-18T17:03:01+11:00 https://pharmadispatch.com/news/pfizer-marks-national-carers-week 2016-10-18T17:00:01+11:00 https://pharmadispatch.com/news/first-pharmacy-trial-getting-underway 2016-10-19T17:00:01+11:00 https://pharmadispatch.com/news/coalition-sticking-with-the-politics-of-pbs 2016-10-19T17:02:01+11:00 https://pharmadispatch.com/news/janssen-marks-prezcobix-listing 2016-10-19T17:01:01+11:00 https://pharmadispatch.com/news/health-minister-sussan-leys-speech-to-rare-cancers-australia-for 2016-10-19T17:03:01+11:00 https://pharmadispatch.com/news/pbac-chair-steps-in-on-pbs-changes 2016-10-19T17:05:01+11:00 https://pharmadispatch.com/news/highlights-from-day-one-of-the-canberra-forum 2016-10-19T17:04:01+11:00 https://pharmadispatch.com/news/a-rare-moment-in-time 2016-10-19T17:06:01+11:00 https://pharmadispatch.com/news/government-sticks-with-savings 2016-10-20T17:04:01+11:00 https://pharmadispatch.com/news/ma-debates-board-changes 2016-10-20T17:03:01+11:00 https://pharmadispatch.com/news/further-confirmation-of-pbs-jump 2016-10-20T17:02:01+11:00 https://pharmadispatch.com/news/acquisition-and-capital-raise-for-medadvisor 2016-10-20T17:00:01+11:00 https://pharmadispatch.com/news/new-80-million-molecular-and-life-sciences-research-centre 2016-10-20T17:01:01+11:00 https://pharmadispatch.com/news/minister-had-to-fight-on-lsdp 2016-10-21T17:00:01+11:00 https://pharmadispatch.com/news/retail-underpins-api-profit-growth 2016-10-21T17:00:01+11:00 https://pharmadispatch.com/news/busy-year-for-pbac 2016-10-21T17:00:01+11:00 https://pharmadispatch.com/news/prostheses-cuts-very-different-to-the-pbs 2016-10-21T17:00:01+11:00 https://pharmadispatch.com/news/spittle-a-difference-between-listening-and-hearing 2016-10-24T17:00:01+11:00 https://pharmadispatch.com/news/price-negotiator-to-join-ex-pbac-chair-in-geneva 2016-10-24T17:04:01+11:00 https://pharmadispatch.com/news/anticipated-study-backs-inflximab-switch 2016-10-24T17:03:01+11:00 https://pharmadispatch.com/news/cancer-australia-marks-pink-ribbon-day-with-new-breast-cancer-st 2016-10-24T17:02:01+11:00 https://pharmadispatch.com/news/terry-white-group-shareholders-approve-chemmart-merger 2016-10-24T17:01:01+11:00 https://pharmadispatch.com/news/biotech-sector-gathers-in-melbourne 2016-10-24T17:00:01+11:00 https://pharmadispatch.com/news/no-shortage-of-dance-partners-for-industry 2016-10-25T17:05:01+11:00 https://pharmadispatch.com/news/minister-acts-on-industry-forum 2016-10-25T17:06:01+11:00 https://pharmadispatch.com/news/gsk-teams-up-with-victoria-on-manufacturing 2016-10-25T17:02:01+11:00 https://pharmadispatch.com/news/industry-front-and-centre-of-growth-centre-grants 2016-10-25T17:03:01+11:00 https://pharmadispatch.com/news/guild-wary-of-ramsay-pharmacy-move 2016-10-25T17:01:01+11:00 https://pharmadispatch.com/news/new-report-highlights-biotech-potential 2016-10-25T17:04:01+11:00 https://pharmadispatch.com/news/next-round-of-pharmacy-trials 2016-10-25T17:00:01+11:00 https://pharmadispatch.com/news/the-language-will-give-it-away 2016-10-26T17:00:01+11:00 https://pharmadispatch.com/news/new-us-approval-for-keytruda 2016-10-26T17:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-jj-innovation-industry-excellence-awards 2016-10-26T17:00:01+11:00 https://pharmadispatch.com/news/when-growth-is-no-growth 2016-10-26T17:00:01+11:00 https://pharmadispatch.com/news/chf-backs-wider-role-for-pharmacy 2016-10-26T17:00:01+11:00 https://pharmadispatch.com/news/pharmaceutical-prices-fall-in-september-quarter 2016-10-27T17:03:01+11:00 https://pharmadispatch.com/news/careful-what-you-wish-for-on-rebates 2016-10-27T17:04:01+11:00 https://pharmadispatch.com/news/swisse-partners-with-csiro 2016-10-27T17:02:01+11:00 https://pharmadispatch.com/news/new-brand-for-terry-white-and-chemmart 2016-10-27T17:00:01+11:00 https://pharmadispatch.com/news/chief-scientist-defends-rd-tax-cap 2016-10-27T17:01:01+11:00 https://pharmadispatch.com/news/university-of-melbourne-joins-pfizer-research-network 2016-10-28T17:01:01+11:00 https://pharmadispatch.com/news/tough-quarter-for-blackmores 2016-10-28T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-commits-20-million-to-australian-clinical-trials 2016-10-28T17:02:01+11:00 https://pharmadispatch.com/news/come-to-me-with-your-ideas 2016-10-28T17:05:01+11:00 https://pharmadispatch.com/news/minister-could-reinvigorate-the-reinvigorated-amwg 2016-10-28T17:03:01+11:00 https://pharmadispatch.com/news/between-a-rock-and-a-hard-place 2016-10-28T17:04:01+11:00 https://pharmadispatch.com/news/treatment-naive-only-would-not-work-says-pbac 2016-10-31T17:00:01+11:00 https://pharmadispatch.com/news/pbac-doing-exactly-what-it-said 2016-10-31T17:00:01+11:00 https://pharmadispatch.com/news/specialists-drive-use-of-noacs 2016-10-31T17:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-major-new-listings 2016-10-31T17:00:01+11:00 https://pharmadispatch.com/news/six-monthly-eye-implant-for-pbs 2016-10-31T17:00:01+11:00 https://pharmadispatch.com/news/tillack-increases-show-gmwg-has-a-heartbeat 2016-11-01T17:04:01+11:00 https://pharmadispatch.com/news/price-increases-may-not-be-one-off 2016-11-01T17:03:01+11:00 https://pharmadispatch.com/news/jj-partners-with-day-of-stem 2016-11-01T17:00:01+11:00 https://pharmadispatch.com/news/extension-for-pharmacy-review 2016-11-01T17:02:01+11:00 https://pharmadispatch.com/news/consultation-underway-on-tga-reforms 2016-11-01T17:01:01+11:00 https://pharmadispatch.com/news/business-group-opposes-ip-extension-for-biologics 2016-11-02T17:00:01+11:00 https://pharmadispatch.com/news/simple-error-causes-problems-for-gsk 2016-11-02T17:00:01+11:00 https://pharmadispatch.com/news/blood-authority-annual-report 2016-11-02T17:00:01+11:00 https://pharmadispatch.com/news/minister-to-launch-national-shingles-vaccination-program 2016-11-02T17:00:01+11:00 https://pharmadispatch.com/news/australia-falling-behind-on-pharma-innovation 2016-11-03T17:04:01+11:00 https://pharmadispatch.com/news/prescribing-shift-impacts-hospital-drug-spend 2016-11-03T17:03:01+11:00 https://pharmadispatch.com/news/industry-watching-for-any-change-on-comparators 2016-11-03T17:02:01+11:00 https://pharmadispatch.com/news/priceline-launches-new-marketing-creative 2016-11-03T17:00:01+11:00 https://pharmadispatch.com/news/the-work-is-already-done 2016-11-03T17:01:01+11:00 https://pharmadispatch.com/news/gsk-announces-sydney-plant-closure 2016-11-04T17:00:01+11:00 https://pharmadispatch.com/news/abc-announces-changes-to-catalyst 2016-11-04T17:00:01+11:00 https://pharmadispatch.com/news/bayer-extends-support-for-heart-of-australia 2016-11-04T17:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-clarity-on-data-protection 2016-11-04T17:00:01+11:00 https://pharmadispatch.com/news/bionomics-msd-symposium-in-adelaide 2016-11-07T17:01:01+11:00 https://pharmadispatch.com/news/maybe-caught-in-ongoing-us-investigation 2016-11-07T17:02:01+11:00 https://pharmadispatch.com/news/government-announces-global-innovation-strategy 2016-11-07T17:03:01+11:00 https://pharmadispatch.com/news/the-fiscal-challenge-and-making-reform-work 2016-11-07T17:04:01+11:00 https://pharmadispatch.com/news/leaks-reveal-politics-of-drug-pricing 2016-11-07T17:00:01+11:00 https://pharmadispatch.com/news/no-pbs-changes-as-a-result-of-tpp 2016-11-08T17:00:01+11:00 https://pharmadispatch.com/news/nps-claims-75m-in-pbs-savings 2016-11-08T17:02:01+11:00 https://pharmadispatch.com/news/mtpconnect-wants-action-on-clinical-trials 2016-11-08T17:01:01+11:00 https://pharmadispatch.com/news/stay-up-to-date 2016-11-08T02:52:01+11:00 https://pharmadispatch.com/news/labor-calls-for-political-intervention 2016-11-08T17:04:01+11:00 https://pharmadispatch.com/news/sussan-ley-labor-plan-against-australian-law 2016-11-09T17:00:01+11:00 https://pharmadispatch.com/news/pharmacy-pay-dispute 2016-11-09T17:00:01+11:00 https://pharmadispatch.com/news/political-intervention-on-this-really 2016-11-09T17:00:01+11:00 https://pharmadispatch.com/news/turnbull-government-maintains-pbs-focus 2016-11-09T17:00:01+11:00 https://pharmadispatch.com/news/generics-dump-price-discounts 2016-11-10T17:04:01+11:00 https://pharmadispatch.com/news/trump-victory-means-change-for-pharma 2016-11-10T17:03:01+11:00 https://pharmadispatch.com/news/tga-consults-on-advertising-regulation 2016-11-10T17:00:01+11:00 https://pharmadispatch.com/news/research-australia-welcomes-mrff-strategy 2016-11-10T17:01:01+11:00 https://pharmadispatch.com/news/dusc-september-outcome-statement 2016-11-10T17:02:01+11:00 https://pharmadispatch.com/news/ma-calls-for-board-nominations 2016-11-11T17:05:01+11:00 https://pharmadispatch.com/news/gsk-consumer-the-big-winner-at-sigma-supplier-awards 2016-11-11T17:02:01+11:00 https://pharmadispatch.com/news/ministers-announce-new-antimicrobial-resistance-strategy 2016-11-11T17:01:01+11:00 https://pharmadispatch.com/news/new-advice-on-pharmacy-integration-with-gp 2016-11-11T17:00:01+11:00 https://pharmadispatch.com/news/investors-decide-trump-victory-better-than-the-alternative 2016-11-11T17:04:01+11:00 https://pharmadispatch.com/news/pfizer-could-sell-consumer-health-business 2016-11-11T17:03:01+11:00 https://pharmadispatch.com/news/tpp-demise-means-different-things-in-australia-and-nz 2016-11-14T17:00:01+11:00 https://pharmadispatch.com/news/turnbull-weve-got-to-own-up-to-the-vulnerability-in-health 2016-11-14T17:00:01+11:00 https://pharmadispatch.com/news/minister-launches-first-pharmacy-trial 2016-11-14T17:00:01+11:00 https://pharmadispatch.com/news/zostavax-shortage-hits 2016-11-14T17:00:01+11:00 https://pharmadispatch.com/news/halton-the-human-element-of-reform 2016-11-14T17:00:01+11:00 https://pharmadispatch.com/news/hcv-therapies-break-2bn-mark 2016-11-15T17:04:01+11:00 https://pharmadispatch.com/news/gsk-tops-access-to-medicine-index 2016-11-15T17:02:01+11:00 https://pharmadispatch.com/news/viiv-partners-with-napwha-on-patient-app 2016-11-16T05:01:01+11:00 https://pharmadispatch.com/news/prime-minister-opens-monash-biomedicine-discovery-institute-1 2016-11-15T17:00:01+11:00 https://pharmadispatch.com/news/youre-not-different-and-youre-not-special 2016-11-15T17:05:01+11:00 https://pharmadispatch.com/news/novartis-looking-at-amneal 2016-11-15T17:03:01+11:00 https://pharmadispatch.com/news/pbs-for-amgens-cholesterol-lowering-biologic 2016-11-16T17:03:01+11:00 https://pharmadispatch.com/news/industry-leaders-pay-tribute-to-halton 2016-11-16T17:04:01+11:00 https://pharmadispatch.com/news/pharmaxis-signs-collaboration-with-woolcock-institute 2016-11-16T17:00:01+11:00 https://pharmadispatch.com/news/cancer-is-different-says-canadian-expert 2016-11-21T17:05:01+11:00 https://pharmadispatch.com/news/stakeholders-gather-for-pharmacy-forum 2016-11-16T17:01:01+11:00 https://pharmadispatch.com/news/halton-random-acts-of-violence-are-going-to-happen-sometimes 2016-11-16T17:05:01+11:00 https://pharmadispatch.com/news/rmit-recognised-at-global-quickfire-challenge 2016-11-16T17:02:01+11:00 https://pharmadispatch.com/news/positive-news-for-sussan-ley 2016-11-17T17:04:01+11:00 https://pharmadispatch.com/news/is-anyone-listening 2016-11-17T17:03:01+11:00 https://pharmadispatch.com/news/medical-research-community-recognises-achievement 2016-11-17T17:00:01+11:00 https://pharmadispatch.com/news/study-backs-pradaxa-reversal-agent 2016-11-17T17:02:01+11:00 https://pharmadispatch.com/news/gsk-award-recognises-research-focussed-on-chronic-conditions 2016-11-17T17:01:01+11:00 https://pharmadispatch.com/news/government-resisting-push-for-dispensing-fee-increase 2016-11-18T17:05:01+11:00 https://pharmadispatch.com/news/nervous-times-for-diabetes-companies 2016-11-18T17:04:01+11:00 https://pharmadispatch.com/news/roche-navigates-comparator-issue-with-new-actemra-listing 2016-11-18T17:03:01+11:00 https://pharmadispatch.com/news/sa-health-minister-calls-for-bexsero-funding 2016-11-18T17:01:01+11:00 https://pharmadispatch.com/news/expansion-for-emerging-australian-poppy-processor 2016-11-18T17:00:01+11:00 https://pharmadispatch.com/news/martin-bowles-talks-up-health-reform-agenda 2016-11-18T17:02:01+11:00 https://pharmadispatch.com/news/speeches-to-rare-cancers-australia-forum 2016-11-21T17:00:01+11:00 https://pharmadispatch.com/news/new-cancer-and-asthma-listing-for-1-december 2016-11-21T17:04:01+11:00 https://pharmadispatch.com/news/no-bexsero-funding-without-new-submission 2016-11-21T17:02:01+11:00 https://pharmadispatch.com/news/nz-could-make-minor-concessions-for-us-tpp-support 2016-11-21T17:01:01+11:00 https://pharmadispatch.com/news/bms-welcomes-5th-approval-for-opdivo 2016-11-21T17:03:01+11:00 https://pharmadispatch.com/news/sending-a-very-bad-signal 2016-11-22T17:00:01+11:00 https://pharmadispatch.com/news/innovation-minister-hosts-sector 2016-11-22T17:00:01+11:00 https://pharmadispatch.com/news/pbs-the-template-for-senate-inquiry-into-prostheses-pricing 2016-11-22T17:00:01+11:00 https://pharmadispatch.com/news/novartis-acquires-blood-disease-company 2016-11-22T17:00:01+11:00 https://pharmadispatch.com/news/trump-to-scrap-tpp-on-day-one 2016-11-23T17:02:01+11:00 https://pharmadispatch.com/news/review-a-chance-to-avoid-the-tipping-point 2016-11-23T17:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-building-evidence-against-rd-tax-change 2016-11-23T17:01:01+11:00 https://pharmadispatch.com/news/rising-risk-of-cardiovascular-complacency 2016-11-23T17:03:01+11:00 https://pharmadispatch.com/news/pharmacy-points-to-success-of-codeine-monitoring 2016-11-23T17:00:01+11:00 https://pharmadispatch.com/news/tambassis-seminal-issue-that-goes-to-trust 2016-11-23T17:04:01+11:00 https://pharmadispatch.com/news/cookie-monster-says-no-to-sugar 2016-11-24T17:03:01+11:00 https://pharmadispatch.com/news/turnbull-and-shorten-back-current-pharmacy-model 2016-11-24T17:04:01+11:00 https://pharmadispatch.com/news/bennelong-mp-pays-tribute-to-former-staffer 2016-11-24T17:02:01+11:00 https://pharmadispatch.com/news/gsk-backs-new-study-in-young-smokers 2016-11-24T17:01:01+11:00 https://pharmadispatch.com/news/industry-dominates-auspar-use 2016-11-24T17:00:01+11:00 https://pharmadispatch.com/news/sanofi-pasteur-announces-2016-vaxigrants-recipients 2016-11-25T17:01:01+11:00 https://pharmadispatch.com/news/alzheimers-disappointment-with-failure-of-lillys-bace-inhibitor 2016-11-25T17:02:01+11:00 https://pharmadispatch.com/news/sigma-inks-partnership-with-fred-it 2016-11-25T17:00:01+11:00 https://pharmadispatch.com/news/failures-a-sign-of-industrys-greatness 2016-11-25T17:00:01+11:00 https://pharmadispatch.com/news/jj-confirms-takeover-discussions-with-actelion 2016-11-28T17:03:01+11:00 https://pharmadispatch.com/news/key-ma-staffer-joins-gsk 2016-11-28T17:02:01+11:00 https://pharmadispatch.com/news/api-recognises-industry-at-annual-awards 2016-11-28T17:00:01+11:00 https://pharmadispatch.com/news/labor-moves-to-elevate-health 2016-11-28T17:01:01+11:00 https://pharmadispatch.com/news/the-new-astrazeneca-emerges-in-cambridge 2016-11-28T17:04:01+11:00 https://pharmadispatch.com/news/growing-the-company-rather-than-protecting-it 2016-11-29T17:00:01+11:00 https://pharmadispatch.com/news/uk-expert-biosimilars-fundamental-to-solving-healthcare-affordab 2016-11-29T17:02:01+11:00 https://pharmadispatch.com/news/beards-can-save-lives 2016-11-29T17:01:01+11:00 https://pharmadispatch.com/news/new-licensing-deal-for-starpharma 2016-11-29T17:00:01+11:00 https://pharmadispatch.com/news/gsks-anne-belcher-progress-towards-a-broader-partnership-with-go 2016-11-30T17:03:01+11:00 https://pharmadispatch.com/news/mundipharma-submits-australian-therapy-for-european-approval 2016-11-30T17:00:01+11:00 https://pharmadispatch.com/news/if-you-do-not-fail-it-means-you-do-not-innovate 2016-11-30T17:00:01+11:00 https://pharmadispatch.com/news/new-cancer-senate-inquiry 2016-11-30T17:01:01+11:00 https://pharmadispatch.com/news/five-nominations-for-two-ma-vacancies 2016-12-01T17:04:01+11:00 https://pharmadispatch.com/news/servier-supporting-bowel-cancer-australia-for-decembeard 2016-12-01T17:03:01+11:00 https://pharmadispatch.com/news/new-option-for-australians-with-thyroid-cancer 2016-12-01T17:02:01+11:00 https://pharmadispatch.com/news/children-gain-access-to-asthma-biologic 2016-12-01T17:01:01+11:00 https://pharmadispatch.com/news/jj-raises-actelion-offer 2016-12-01T17:00:01+11:00 https://pharmadispatch.com/news/csl-progresses-three-new-therapies 2016-12-02T17:02:01+11:00 https://pharmadispatch.com/news/guild-issues-reminder-on-workplace-laws 2016-12-02T17:01:01+11:00 https://pharmadispatch.com/news/wider-access-to-eye-therapy 2016-12-02T17:00:01+11:00 https://pharmadispatch.com/news/dr-paul-cornes-lead-or-be-led-on-biosimilars 2016-12-02T17:03:01+11:00 https://pharmadispatch.com/news/change-not-for-the-better 2016-12-05T17:00:01+11:00 https://pharmadispatch.com/news/antibiotics-and-chemo-top-generic-price-increase 2016-12-05T17:03:01+11:00 https://pharmadispatch.com/news/dr-mona-marabani-australia-not-the-uk 2016-12-05T17:02:01+11:00 https://pharmadispatch.com/news/investors-expect-jj-deal-on-actelion 2016-12-05T17:01:01+11:00 https://pharmadispatch.com/news/bruce-goodwin-sitting-on-the-sidelines-not-an-option 2016-12-06T17:00:01+11:00 https://pharmadispatch.com/news/chf-makes-do-with-less 2016-12-05T17:00:01+11:00 https://pharmadispatch.com/news/nps-drug-cost-list-missed-rebates 2016-12-06T03:04:01+11:00 https://pharmadispatch.com/news/novartis-unlikely-to-bid-for-actelion 2016-12-06T17:00:01+11:00 https://pharmadispatch.com/news/minister-announces-funding-for-largest-australian-clinical-trial 2016-12-06T17:00:01+11:00 https://pharmadispatch.com/news/ex-australian-gsk-boss-to-lead-viiv 2016-12-07T17:00:01+11:00 https://pharmadispatch.com/news/sanofi-considering-actelion-bid 2016-12-07T17:00:01+11:00 https://pharmadispatch.com/news/pbs-for-msds-zepatier 2016-12-07T17:00:01+11:00 https://pharmadispatch.com/news/nz-health-minister-joins-pm-race 2016-12-07T17:00:01+11:00 https://pharmadispatch.com/news/more-coming-on-biosimilars 2016-12-08T17:02:01+11:00 https://pharmadispatch.com/news/gsk-invests-to-support-female-entrepreneurs 2016-12-08T17:03:01+11:00 https://pharmadispatch.com/news/government-highlights-innovation-policy-but 2016-12-08T17:01:01+11:00 https://pharmadispatch.com/news/trajan-hosts-innovation-minister 2016-12-08T17:00:01+11:00 https://pharmadispatch.com/news/a-somewhat-misleading-headline 2016-12-08T17:04:01+11:00 https://pharmadispatch.com/news/decem-beard-growing-at-servier 2016-12-08T21:40:01+11:00 https://pharmadispatch.com/news/biosimilar-initiative-goes-live 2016-12-09T16:45:01+11:00 https://pharmadispatch.com/news/medadvisor-inks-deal-with-pfizer 2016-12-09T16:54:01+11:00 https://pharmadispatch.com/news/baxter-recgnised-on-gender 2016-12-09T17:00:01+11:00 https://pharmadispatch.com/news/biosimilar-options-under-consideration 2016-12-12T17:04:01+11:00 https://pharmadispatch.com/news/a-remarkable-year-for-what-was-once-an-afterthought 2016-12-12T17:00:01+11:00 https://pharmadispatch.com/news/ato-publishes-tax-list-as-sector-faces-renewed-scrutiny 2016-12-12T17:03:01+11:00 https://pharmadispatch.com/news/no-agreement-on-dispensing-fee 2016-12-12T17:02:01+11:00 https://pharmadispatch.com/news/trump-fda-choice-says-scrap-efficacy 2016-12-12T17:01:01+11:00 https://pharmadispatch.com/news/collaborative-cancer-research-funding-passes-110m 2016-12-12T17:00:01+11:00 https://pharmadispatch.com/news/budget-challenge-tests-the-limits-of-political-influence 2016-12-13T17:00:01+11:00 https://pharmadispatch.com/news/strange-pbs-request-from-racgp 2016-12-14T17:04:01+11:00 https://pharmadispatch.com/news/seqirus-partners-with-toll 2016-12-13T17:01:01+11:00 https://pharmadispatch.com/news/new-bayer-therapy-for-the-pbs 2016-12-13T17:02:01+11:00 https://pharmadispatch.com/news/pfizer-leadership-helps-santa 2016-12-13T17:03:01+11:00 https://pharmadispatch.com/news/viiv-announces-180000-in-grants 2016-12-13T17:00:01+11:00 https://pharmadispatch.com/news/csl-invests-in-btf-fund 2016-12-14T17:03:01+11:00 https://pharmadispatch.com/news/concessional-patients-dominate-pbs-script-numbers 2016-12-14T17:02:01+11:00 https://pharmadispatch.com/news/leadership-changes-for-alexion 2016-12-14T17:01:01+11:00 https://pharmadispatch.com/news/new-ceo-for-mtaa 2016-12-14T17:00:01+11:00 https://pharmadispatch.com/news/shareholders-back-monsanto-deal-with-bayer 2016-12-15T17:00:01+11:00 https://pharmadispatch.com/news/big-fall-in-pbs-spend-for-2016-17 2016-12-15T17:03:01+11:00 https://pharmadispatch.com/news/tga-still-considering-naming-convention 2016-12-15T17:02:01+11:00 https://pharmadispatch.com/news/sanofi-leads-race-for-actelion-as-jj-drops-out 2016-12-15T17:01:01+11:00 https://pharmadispatch.com/news/a-not-so-merry-christmas-for-bdmard-companies 2016-12-16T17:04:01+11:00 https://pharmadispatch.com/news/first-time-reductions-lead-april-cuts 2016-12-16T17:03:01+11:00 https://pharmadispatch.com/news/decem-beard-enters-week-3-at-servier 2016-12-16T04:28:01+11:00 https://pharmadispatch.com/news/life-science-sector-rallies-against-rd-tax-cut 2016-12-16T17:02:01+11:00 https://pharmadispatch.com/news/new-information-confirms-what-we-already-knew-about-pbs 2016-12-16T17:01:01+11:00 https://pharmadispatch.com/news/former-ausbiotech-ceo-appointed-to-ma-board 2016-12-16T19:45:01+11:00 https://pharmadispatch.com/news/cancer-outcomes-dominate-november-pbac 2016-12-19T17:00:01+11:00 https://pharmadispatch.com/news/official-pbs-stats-confirm-impact-of-hcv-therapies 2016-12-19T17:00:01+11:00 https://pharmadispatch.com/news/gbma-welcomes-a-flag-but-more-required 2016-12-19T17:00:01+11:00 https://pharmadispatch.com/news/minister-announces-new-listings-ahead-of-myefo 2016-12-19T17:00:01+11:00 https://pharmadispatch.com/news/nerves-for-mayne-investors 2016-12-18T17:00:01+11:00 https://pharmadispatch.com/news/two-new-board-members-for-ma 2016-12-19T19:45:01+11:00 https://pharmadispatch.com/news/we-bring-innovation-and-government-should-recognise-it 2016-12-21T17:03:01+11:00 https://pharmadispatch.com/news/no-pbs-surprise-in-myefo 2016-12-20T17:03:01+11:00 https://pharmadispatch.com/news/lower-spending-on-rd-tax-incentive 2016-12-20T17:00:01+11:00 https://pharmadispatch.com/news/exclusive-minister-hits-back-on-unsustainable-orkambi-price 2016-12-20T17:03:01+11:00 https://pharmadispatch.com/news/guild-declares-no-confidence-in-pharmacy-review 2016-12-20T17:02:01+11:00 https://pharmadispatch.com/news/takeda-welcomes-adcetris-recommendation 2016-12-21T17:01:01+11:00 https://pharmadispatch.com/news/codeine-up-schedule-a-silly-decision 2016-12-21T17:02:01+11:00 https://pharmadispatch.com/news/ausbiotech-scrap-rd-tax-cap 2016-12-21T17:00:01+11:00 https://pharmadispatch.com/news/productivity-commission-proposes-a-free-ride-for-australia 2016-12-21T17:04:01+11:00 https://pharmadispatch.com/news/diabetes-companies-receieve-price-cut-dusc-report 2016-12-22T17:04:01+11:00 https://pharmadispatch.com/news/co-pay-delay-for-another-year 2016-12-22T17:01:01+11:00 https://pharmadispatch.com/news/servier-trio-smash-fundraising-target 2016-12-22T17:00:01+11:00 https://pharmadispatch.com/news/managed-entry-on-march-agenda 2016-12-23T17:03:01+11:00 https://pharmadispatch.com/news/jj-back-in-the-hunt-for-actelion 2016-12-22T17:02:01+11:00